,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"2019Annual  ReviewStryker | 2019 Annual Review  Stryker’s technology  improves outcomes for  patient and physician On the day oncoplastic surgeon Dr. Anne  Peled was getting ready to perform  a double mastectomy and breast  reconstruction, her phone rang.
","('Employee_Health_And_Safety', 0.44330450892448425)","('Employee_Engagement_Inclusion_And_Diversity', 0.14106562733650208)","('Access_And_Affordability', 0.09387120604515076)","('NON-ESG', 0.44330450892448425)","('NON-ESG', 0.14106562733650208)","('NON-ESG', 0.09387120604515076)"
Line 2,"She  wasn’t thinking about her own health,  but the news was grim — the disease she  spent her life treating had found her.
","('Employee_Health_And_Safety', 0.4859038293361664)","('Waste_And_Hazardous_Materials_Management', 0.057348959147930145)","('Employee_Engagement_Inclusion_And_Diversity', 0.047347817569971085)","('NON-ESG', 0.4859038293361664)","('NON-ESG', 0.057348959147930145)","('NON-ESG', 0.047347817569971085)"
Line 3,"“I was so shocked,” says Dr. Peled, a  38-year-old vegetarian triathlete who  suspected the lump she discovered, and  had biopsied, was just a cyst.
","('Employee_Health_And_Safety', 0.20510989427566528)","('Employee_Engagement_Inclusion_And_Diversity', 0.15649695694446564)","('Waste_And_Hazardous_Materials_Management', 0.07096240669488907)","('NON-ESG', 0.20510989427566528)","('NON-ESG', 0.15649695694446564)","('NON-ESG', 0.07096240669488907)"
Line 4,"“There  were no words, even though I tell  women about breast cancer diagnoses  many times a week.
","('Employee_Health_And_Safety', 0.37340694665908813)","('Employee_Engagement_Inclusion_And_Diversity', 0.14896437525749207)","('Access_And_Affordability', 0.07174097746610641)","('NON-ESG', 0.37340694665908813)","('NON-ESG', 0.14896437525749207)","('NON-ESG', 0.07174097746610641)"
Line 5,"I had to remind  myself what I tell my patients — that  this is very treatable and, in many   cases, curable.”  With her knowledge and experience,  she was able to put together “an  amazing team of caring and talented  clinicians who really listened to me  and what I wanted,” including her  parents, who are radiation oncologists,  and sister, a medical oncologist.
","('Access_And_Affordability', 0.24224382638931274)","('Product_Quality_And_Safety', 0.12434116005897522)","('Customer_Welfare', 0.09984567016363144)","('NON-ESG', 0.24224382638931274)","('NON-ESG', 0.12434116005897522)","('NON-ESG', 0.09984567016363144)"
Line 6,"“I felt  incredibly grateful for the care and  support I received, and I got through  my treatment smoothly and relatively  easily” — thanks, in part, to the type of  hidden scar surgery she performs on her  own patients.Getting back to feeling  whole During surgery, big scars can appear at  the cancer site, many times in highly  visible locations.
","('Employee_Health_And_Safety', 0.7691352367401123)","('Employee_Engagement_Inclusion_And_Diversity', 0.07036782056093216)","('Product_Design_And_Lifecycle_Management', 0.014968156814575195)","(['Operational Eco-Efficiency'], 0.7691352367401123)","('NON-ESG', 0.07036782056093216)","('NON-ESG', 0.014968156814575195)"
Line 7,"While some women  may see their scars as an empowering  symbol, many do not.
","('Employee_Engagement_Inclusion_And_Diversity', 0.33399489521980286)","('Human_Rights_And_Community_Relations', 0.12714315950870514)","('Customer_Privacy', 0.05868974328041077)","('NON-ESG', 0.33399489521980286)","('NON-ESG', 0.12714315950870514)","('NON-ESG', 0.05868974328041077)"
Line 8,"Research shows  that breast surgery scars may impact a  woman’s psychological and emotional  well-being, as well as quality of life   after surgery.This is where Stryker comes in  with a growing women’s health and  breast cancer portfolio.
","('Employee_Health_And_Safety', 0.762393057346344)","('Employee_Engagement_Inclusion_And_Diversity', 0.06765024363994598)","('Access_And_Affordability', 0.023036440834403038)","(['Operational Eco-Efficiency'], 0.762393057346344)","('NON-ESG', 0.06765024363994598)","('NON-ESG', 0.023036440834403038)"
Line 9,"Case in point:  Stryker’s illuminated instruments for  hidden scar surgery, which can be  used for everything from skin sparing  mastectomies to breast-conserving  procedures (lumpectomy) to total  reconstruction.
","('Employee_Health_And_Safety', 0.8184698224067688)","('Employee_Engagement_Inclusion_And_Diversity', 0.043946072459220886)","('Product_Design_And_Lifecycle_Management', 0.014487924985587597)","(['Operational Eco-Efficiency'], 0.8184698224067688)","('NON-ESG', 0.043946072459220886)","('NON-ESG', 0.014487924985587597)"
Line 10,"With the help of this technology, breast  and plastic surgeons can minimize  scarring with access and visualization  to achieve optimal surgical and  aesthetic outcomes, which help women  move forward feeling more whole  and empowered — and without seeing  reminders of the cancer every day.
","('Employee_Health_And_Safety', 0.8214007019996643)","('Employee_Engagement_Inclusion_And_Diversity', 0.054971132427453995)","('Waste_And_Hazardous_Materials_Management', 0.012526249513030052)","(['Operational Eco-Efficiency'], 0.8214007019996643)","('NON-ESG', 0.054971132427453995)","('NON-ESG', 0.012526249513030052)"
Line 11,"“Stryker’s illuminated instrument  technology makes a huge difference in  performing hidden scar techniques,”  says Dr. Peled.
","('Employee_Health_And_Safety', 0.40507689118385315)","('Supply_Chain_Management', 0.16305382549762726)","('Product_Design_And_Lifecycle_Management', 0.05372742563486099)","('NON-ESG', 0.40507689118385315)","('NON-ESG', 0.16305382549762726)","('NON-ESG', 0.05372742563486099)"
Line 12,"“I believe it’s safer and  more efficient than other products on  1.
","('Product_Design_And_Lifecycle_Management', 0.952015221118927)","('Product_Quality_And_Safety', 0.007029031403362751)","('Energy_Management', 0.0051801749505102634)","(['Product Stewardship'], 0.952015221118927)","('NON-ESG', 0.007029031403362751)","('NON-ESG', 0.0051801749505102634)"
Line 13,"Gass J, et al.
","('GHG_Emissions', 0.3144623041152954)","('Management_Of_Legal_And_Regulatory_Framework', 0.14596040546894073)","('Ecological_Impacts', 0.12526869773864746)","('NON-ESG', 0.3144623041152954)","('NON-ESG', 0.14596040546894073)","('NON-ESG', 0.12526869773864746)"
Line 14,"How do breast cancer surgery scars impact survivorship?
","('Employee_Health_And_Safety', 0.8395830988883972)","('Employee_Engagement_Inclusion_And_Diversity', 0.0326421894133091)","('Access_And_Affordability', 0.020467977970838547)","(['Operational Eco-Efficiency'], 0.8395830988883972)","('NON-ESG', 0.0326421894133091)","('NON-ESG', 0.020467977970838547)"
Line 15,"Findings from a nationwide  survey in the United States.
","('Management_Of_Legal_And_Regulatory_Framework', 0.211891308426857)","('Employee_Engagement_Inclusion_And_Diversity', 0.12858176231384277)","('Competitive_Behavior', 0.09553952515125275)","('NON-ESG', 0.211891308426857)","('NON-ESG', 0.12858176231384277)","('NON-ESG', 0.09553952515125275)"
Line 16,"BMC Cancer (2019) 19:342.
","('Ecological_Impacts', 0.18868330121040344)","('Systemic_Risk_Management', 0.10863283276557922)","('Access_And_Affordability', 0.08339980244636536)","('NON-ESG', 0.18868330121040344)","('NON-ESG', 0.10863283276557922)","('NON-ESG', 0.08339980244636536)"
Line 17,"https://doi.org/10.1186/s12885-019-5553-0.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3357457220554352)","('Ecological_Impacts', 0.15066780149936676)","('GHG_Emissions', 0.04509661719202995)","('NON-ESG', 0.3357457220554352)","('NON-ESG', 0.15066780149936676)","('NON-ESG', 0.04509661719202995)"
Line 18,"Accessed 10/2019.When the breast   cancer surgeon  becomes the patient, expertise, emotions  and empathy come  togetherStryker | 2019 Annual Review  3the market, with superior design and  quality.
","('Product_Design_And_Lifecycle_Management', 0.18094666302204132)","('Employee_Engagement_Inclusion_And_Diversity', 0.12088035047054291)","('Product_Quality_And_Safety', 0.08970778435468674)","('NON-ESG', 0.18094666302204132)","('NON-ESG', 0.12088035047054291)","('NON-ESG', 0.08970778435468674)"
Line 19,"And patients look as good, if not  better, than before, so they can more  easily move past treatment.” “This technology provides surgeons  access and visualization during surgery  to achieve optimal surgical and aesthetic  outcomes, including minimally invasive  surgeries,” says Charles Henkel, Stryker  Sales Manager, Surgical Technologies.
","('Employee_Health_And_Safety', 0.46709752082824707)","('Employee_Engagement_Inclusion_And_Diversity', 0.13032273948192596)","('Access_And_Affordability', 0.06789832562208176)","('NON-ESG', 0.46709752082824707)","('NON-ESG', 0.13032273948192596)","('NON-ESG', 0.06789832562208176)"
Line 20,"Moving on with life and  career As an advocate of hidden scar  surgery — as well as a new procedure  she developed with her husband, plastic  surgeon Ziv Peled, to preserve nerve  sensation in the breast — Dr. Peled travels the country to train colleagues in  the surgical technique she experienced  as a patient.
","('Employee_Health_And_Safety', 0.8308774828910828)","('Employee_Engagement_Inclusion_And_Diversity', 0.04759407415986061)","('Product_Design_And_Lifecycle_Management', 0.01115015521645546)","(['Operational Eco-Efficiency'], 0.8308774828910828)","('NON-ESG', 0.04759407415986061)","('NON-ESG', 0.01115015521645546)"
Line 21,"She also talks about the  technique on social media and invites  surgeons to come to her practice to  watch and learn.
","('Access_And_Affordability', 0.3340873122215271)","('Employee_Engagement_Inclusion_And_Diversity', 0.12857556343078613)","('Employee_Health_And_Safety', 0.0647912472486496)","('NON-ESG', 0.3340873122215271)","('NON-ESG', 0.12857556343078613)","('NON-ESG', 0.0647912472486496)"
Line 22,"Dr. Peled has found that sharing her  story can be especially helpful for her  younger patients, because the fears,  challenges and decision-making around  breast cancer can be very different than  for older women, and peer support can  be even more important.
","('Access_And_Affordability', 0.42698782682418823)","('Employee_Engagement_Inclusion_And_Diversity', 0.16093656420707703)","('Employee_Health_And_Safety', 0.12194131314754486)","('NON-ESG', 0.42698782682418823)","('NON-ESG', 0.16093656420707703)","('NON-ESG', 0.12194131314754486)"
Line 23,"“I can share ‘insider tips’ on getting  through the care,” she explains.
","('Systemic_Risk_Management', 0.20529040694236755)","('Competitive_Behavior', 0.14989124238491058)","('Data_Security', 0.14629928767681122)","('NON-ESG', 0.20529040694236755)","('NON-ESG', 0.14989124238491058)","('NON-ESG', 0.14629928767681122)"
Line 24,"“Many  patients who know about my own  diagnosis will reach out to ask questions  about my experience as they go through  “ I had to remind myself what I tell my  patients —  that this is very treatable  and, in many cases, curable.” — Dr. Anne Peledtheir treatment, and I love the way  this connects me to them in a totally  different way.” With colleagues, Dr. Peled has learned  to carefully draw from her personal  experience to make productive, patient- focused suggestions, which she believes  may carry some weight.
","('Employee_Health_And_Safety', 0.19235719740390778)","('Access_And_Affordability', 0.18778136372566223)","('Employee_Engagement_Inclusion_And_Diversity', 0.1218639686703682)","('NON-ESG', 0.19235719740390778)","('NON-ESG', 0.18778136372566223)","('NON-ESG', 0.1218639686703682)"
Line 25,"“Many  patients who know about my own  diagnosis will reach out to ask questions  about my experience as they go through  “ I had to remind myself what I tell my  patients —  that this is very treatable  and, in many cases, curable.” — Dr. Anne Peledtheir treatment, and I love the way  this connects me to them in a totally  different way.” With colleagues, Dr. Peled has learned  to carefully draw from her personal  experience to make productive, patient- focused suggestions, which she believes  may carry some weight.
","('Waste_And_Hazardous_Materials_Management', 0.08783234655857086)","('Competitive_Behavior', 0.0868404284119606)","('Customer_Welfare', 0.08626754581928253)","('NON-ESG', 0.08783234655857086)","('NON-ESG', 0.0868404284119606)","('NON-ESG', 0.08626754581928253)"
Line 26,"“ As I settle into these dual and  simultaneous roles of breast cancer  surgeon and breast cancer survivor,  I’m gradually balancing the interplay  of these parts of myself into my  relationships with both patients and  colleagues,” she says.
","('Employee_Health_And_Safety', 0.35128429532051086)","('Employee_Engagement_Inclusion_And_Diversity', 0.2705731689929962)","('Access_And_Affordability', 0.05400087311863899)","('NON-ESG', 0.35128429532051086)","('NON-ESG', 0.2705731689929962)","('NON-ESG', 0.05400087311863899)"
Line 27,"“For now, I take it  one interaction at a time and bask in the  deeply connecting moments of shared  understanding when they happen.” Charles Henkel Stryker Sales Manager,   Surgical TechnologiesSYK 2019 Annual Review  022317  SYK_AR19_v14  03/17 /20  page “ Patients look as good, if not   better than before, so they can  more easily move past treatment.” — Dr. Anne PeledStryker | 2019 Annual Review  SPY Fluorescence: improving visualization  in breast reconstruction When two of her sisters had breast  cancer, 51-year-old Barbara Pink, the  baby of the family, was aware that she  might be next, knowing that women  with “first degree” relatives with breast  cancer are at an increased risk.
","('Employee_Health_And_Safety', 0.5517688989639282)","('Employee_Engagement_Inclusion_And_Diversity', 0.13172051310539246)","('Access_And_Affordability', 0.04671799764037132)","(['Operational Eco-Efficiency'], 0.5517688989639282)","('NON-ESG', 0.13172051310539246)","('NON-ESG', 0.04671799764037132)"
Line 28,"“For now, I take it  one interaction at a time and bask in the  deeply connecting moments of shared  understanding when they happen.” Charles Henkel Stryker Sales Manager,   Surgical TechnologiesSYK 2019 Annual Review  022317  SYK_AR19_v14  03/17 /20  page “ Patients look as good, if not   better than before, so they can  more easily move past treatment.” — Dr. Anne PeledStryker | 2019 Annual Review  SPY Fluorescence: improving visualization  in breast reconstruction When two of her sisters had breast  cancer, 51-year-old Barbara Pink, the  baby of the family, was aware that she  might be next, knowing that women  with “first degree” relatives with breast  cancer are at an increased risk.
","('Employee_Health_And_Safety', 0.48847246170043945)","('Employee_Engagement_Inclusion_And_Diversity', 0.16073079407215118)","('Access_And_Affordability', 0.055864203721284866)","('NON-ESG', 0.48847246170043945)","('NON-ESG', 0.16073079407215118)","('NON-ESG', 0.055864203721284866)"
Line 29,"Barbara learned about her diagnosis  following a mammogram.
","('Employee_Health_And_Safety', 0.3500220775604248)","('Employee_Engagement_Inclusion_And_Diversity', 0.1852157562971115)","('Access_And_Affordability', 0.1363244205713272)","('NON-ESG', 0.3500220775604248)","('NON-ESG', 0.1852157562971115)","('NON-ESG', 0.1363244205713272)"
Line 30,"“Because of  my sisters, I wasn’t shocked,” Barbara  says.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6431072354316711)","('Director_Removal', 0.03086831420660019)","('Business_Ethics', 0.027003632858395576)","(['Human Capital Development'], 0.6431072354316711)","('NON-ESG', 0.03086831420660019)","('NON-ESG', 0.027003632858395576)"
Line 31,"“I was around the same age as they  were when they were diagnosed.”  But with an aggressive form of breast  cancer, Barbara made the decision  to get a bilateral mastectomy and  bilateral breast reconstruction, an  increasingly common choice for many  women.
","('Employee_Health_And_Safety', 0.3530912697315216)","('Employee_Engagement_Inclusion_And_Diversity', 0.27065309882164)","('Access_And_Affordability', 0.08739331364631653)","('NON-ESG', 0.3530912697315216)","('NON-ESG', 0.27065309882164)","('NON-ESG', 0.08739331364631653)"
Line 32,"In fact, the number of breast  cancer patients opting for implant  reconstruction after a mastectomy has  increased by two-thirds.1  Barbara’s plastic surgeon, Dr. Charles  Kays, from Wilmington Plastic Surgery,  in Wilmington, North Carolina, says the  number of cases where the mastectomy  and implant reconstruction are done  at one time, rather than two separate  surgeries, is also becoming more common.
","('Employee_Health_And_Safety', 0.5850140452384949)","('Employee_Engagement_Inclusion_And_Diversity', 0.13308307528495789)","('Access_And_Affordability', 0.04015720263123512)","(['Operational Eco-Efficiency'], 0.5850140452384949)","('NON-ESG', 0.13308307528495789)","('NON-ESG', 0.04015720263123512)"
Line 33,"“There’s a lot of emotional trauma to  having your breasts removed and not  completing your reconstruction at the  time of surgery.
","('Employee_Health_And_Safety', 0.8299826383590698)","('Employee_Engagement_Inclusion_And_Diversity', 0.036710482090711594)","('Customer_Privacy', 0.010434123687446117)","(['Operational Eco-Efficiency'], 0.8299826383590698)","('NON-ESG', 0.036710482090711594)","('NON-ESG', 0.010434123687446117)"
Line 34,"When we perform both  at the same time, patients are relieved  to get the procedure over with and their  overall recovery is shorter,” he says.Dr. Kays took advantage of Stryker’s  innovative SPY fluorescence imaging  technology during the complicated  operation.
","('Employee_Health_And_Safety', 0.5644716024398804)","('Access_And_Affordability', 0.08081988245248795)","('Critical_Incident_Risk_Management', 0.05376069247722626)","(['Operational Eco-Efficiency'], 0.5644716024398804)","('NON-ESG', 0.08081988245248795)","('NON-ESG', 0.05376069247722626)"
Line 35,"With SPY fluorescence, surgical  teams can better visualize anatomy and  blood flow in vessels and related tissue,  which may improve outcomes in the  operating room.After the surgery, Barbara was up and  around in just a few days and fully back  in action after only four weeks.
","('Employee_Health_And_Safety', 0.6417631506919861)","('Critical_Incident_Risk_Management', 0.03367563709616661)","('Access_And_Affordability', 0.03364616632461548)","(['Operational Eco-Efficiency'], 0.6417631506919861)","('NON-ESG', 0.03367563709616661)","('NON-ESG', 0.03364616632461548)"
Line 36,"“I was  thrilled and my sisters were thrilled,” says  Barbara.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4344549775123596)","('Management_Of_Legal_And_Regulatory_Framework', 0.06658823043107986)","('Human_Rights_And_Community_Relations', 0.05291211977601051)","('NON-ESG', 0.4344549775123596)","('NON-ESG', 0.06658823043107986)","('NON-ESG', 0.05291211977601051)"
Line 37,"“I had amazing care, and I’m just  so happy to move ahead with my life.” 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.23130418360233307)","('Business_Model_Resilience', 0.10306836664676666)","('Product_Design_And_Lifecycle_Management', 0.09478558599948883)","('NON-ESG', 0.23130418360233307)","('NON-ESG', 0.10306836664676666)","('NON-ESG', 0.09478558599948883)"
Line 38,"U.S. Agency for Healthcare Research and Quality 2009.
","('Access_And_Affordability', 0.23361259698867798)","('Management_Of_Legal_And_Regulatory_Framework', 0.17547035217285156)","('Product_Quality_And_Safety', 0.09867892414331436)","('NON-ESG', 0.23361259698867798)","('NON-ESG', 0.17547035217285156)","('NON-ESG', 0.09867892414331436)"
Line 39,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 40,"SPY clinical bibliography available upon request.Stryker | 2019 Annual Review  Dear   shareholders, “ We had an excellent year in 2019,  as we reached 40 consecutive  years of sales growth.” — Kevin Lobo  Chairman and Chief Executive OfficerWe had an excellent year in 2019, as we  reached 40 consecutive years of sales growth  and recorded our seventh consecutive year  of accelerated organic sales growth.
","('Business_Model_Resilience', 0.5434688329696655)","('Systemic_Risk_Management', 0.12033542990684509)","('Director_Removal', 0.03735044598579407)","(['Codes of Business Conduct'], 0.5434688329696655)","('NON-ESG', 0.12033542990684509)","('NON-ESG', 0.03735044598579407)"
Line 41,"We also  posted strong adjusted net earnings per share  and continued to execute on our strategy of  customer focus, innovation, globalization and  cost transformation.
","('Business_Model_Resilience', 0.548688530921936)","('Competitive_Behavior', 0.13606619834899902)","('Systemic_Risk_Management', 0.08473052084445953)","(['Codes of Business Conduct'], 0.548688530921936)","('NON-ESG', 0.13606619834899902)","('NON-ESG', 0.08473052084445953)"
Line 42,"Culture and leadership The bedrock of our company is our  mission —  Together with our customers, we  are driven to make healthcare better —  and  values: Integrity, Accountability, People and  Performance.
","('Business_Ethics', 0.4638672471046448)","('Employee_Engagement_Inclusion_And_Diversity', 0.14845149219036102)","('Human_Rights_And_Community_Relations', 0.07382897287607193)","('NON-ESG', 0.4638672471046448)","('NON-ESG', 0.14845149219036102)","('NON-ESG', 0.07382897287607193)"
Line 43,"We hire people who are driven,  team-oriented and humble.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6700376868247986)","('Business_Model_Resilience', 0.0542684867978096)","('Human_Rights_And_Community_Relations', 0.044440027326345444)","(['Human Capital Development'], 0.6700376868247986)","('NON-ESG', 0.0542684867978096)","('NON-ESG', 0.044440027326345444)"
Line 44,"We continue to be  regarded as a great place to work (see page 16)  and are honored by the accolades that reflect  our inclusive culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9203249216079712)","('Human_Rights_And_Community_Relations', 0.013758962973952293)","('Employee_Health_And_Safety', 0.007606951519846916)","(['Human Capital Development'], 0.9203249216079712)","('NON-ESG', 0.013758962973952293)","('NON-ESG', 0.007606951519846916)"
Line 45,"We’re pleased to have  been rated #1 best workplace for diversity in  the U.S. by Fortune and Great Place to Work.We will have one change to our Board  of Directors as Louise Francesconi has  announced that she will not stand for  re-election in May 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9670475125312805)","('Human_Rights_And_Community_Relations', 0.0028243011329323053)","('Employee_Health_And_Safety', 0.00265211402438581)","(['Human Capital Development'], 0.9670475125312805)","('NON-ESG', 0.0028243011329323053)","('NON-ESG', 0.00265211402438581)"
Line 46,"Louise has made  strong contributions during her 14 years on  our Board and we thank her for her dedicated  service (see page 20).
","('Director_Removal', 0.4452778995037079)","('Management_Of_Legal_And_Regulatory_Framework', 0.11785779893398285)","('Business_Model_Resilience', 0.0575493760406971)","('NON-ESG', 0.4452778995037079)","('NON-ESG', 0.11785779893398285)","('NON-ESG', 0.0575493760406971)"
Line 47,"Financial performance Our U.S. and international organic sales  growth were both 8.1 percent, with strong  international performances in emerging  markets and Europe.
","('Business_Model_Resilience', 0.2746739387512207)","('Systemic_Risk_Management', 0.23455409705638885)","('Competitive_Behavior', 0.14862070977687836)","('NON-ESG', 0.2746739387512207)","('NON-ESG', 0.23455409705638885)","('NON-ESG', 0.14862070977687836)"
Line 48,"Reported sales growth  was 9.4 percent, including 2.6 percent growth  from acquisitions and 9.0 percent growth  from increased unit volume, which was  partially offset by a 1.3 percent impact from  foreign exchange and a 0.9 percent impact  from lower prices.Stryker | 2019 Annual Review  7results for our employees, customers,  communities and the planet.
","('Business_Model_Resilience', 0.34711316227912903)","('Competitive_Behavior', 0.13063989579677582)","('Systemic_Risk_Management', 0.11136586219072342)","('NON-ESG', 0.34711316227912903)","('NON-ESG', 0.13063989579677582)","('NON-ESG', 0.11136586219072342)"
Line 49,"Reflecting on our 2019 accomplishments,  I would like to thank our management  teams, our Board of Directors and our  roughly 40,000 employees worldwide  who live our mission and values every  day.
","('Director_Removal', 0.4085634648799896)","('Business_Model_Resilience', 0.11120402067899704)","('Employee_Engagement_Inclusion_And_Diversity', 0.0995551198720932)","('NON-ESG', 0.4085634648799896)","('NON-ESG', 0.11120402067899704)","('NON-ESG', 0.0995551198720932)"
Line 50,"Our strategy, people and culture  will enable us to continue to deliver  strong performance in the years ahead.
","('Human_Rights_And_Community_Relations', 0.34557846188545227)","('Employee_Engagement_Inclusion_And_Diversity', 0.2778080403804779)","('Business_Model_Resilience', 0.10706731677055359)","('NON-ESG', 0.34557846188545227)","('NON-ESG', 0.2778080403804779)","('NON-ESG', 0.10706731677055359)"
Line 51,"Kevin A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.17241306602954865)","('Business_Ethics', 0.1270178258419037)","('Employee_Engagement_Inclusion_And_Diversity', 0.06355806440114975)","('NON-ESG', 0.17241306602954865)","('NON-ESG', 0.1270178258419037)","('NON-ESG', 0.06355806440114975)"
Line 52,"Lobo Chairman and Chief Executive Officer on track to roll it out to our other  businesses across the world over the  next few years.
","('Business_Model_Resilience', 0.5567517876625061)","('Director_Removal', 0.12221693247556686)","('Systemic_Risk_Management', 0.042233437299728394)","(['Codes of Business Conduct'], 0.5567517876625061)","('NON-ESG', 0.12221693247556686)","('NON-ESG', 0.042233437299728394)"
Line 53,"We also made significant  progress with our finance shared  services, including starting up a center  in Costa Rica, and continued to drive  improvements within our supply chain.
","('Supply_Chain_Management', 0.9425463676452637)","('Labor_Practices', 0.00463778106495738)","('Water_And_Wastewater_Management', 0.0041897776536643505)","(['Supply Chain Management'], 0.9425463676452637)","('NON-ESG', 0.00463778106495738)","('NON-ESG', 0.0041897776536643505)"
Line 54,"Community We are working to improve healthcare  responsibly and sustainably because  we believe the health of the world is as  important as the people who live in it.
","('Employee_Health_And_Safety', 0.43244093656539917)","('Access_And_Affordability', 0.279435396194458)","('Human_Rights_And_Community_Relations', 0.043288055807352066)","('NON-ESG', 0.43244093656539917)","('NON-ESG', 0.279435396194458)","('NON-ESG', 0.043288055807352066)"
Line 55,"Our activities and progress are outlined  in our Corporate Responsibility Review,  which is available on our website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2211962640285492)","('Business_Model_Resilience', 0.20486527681350708)","('Human_Rights_And_Community_Relations', 0.1589866727590561)","('NON-ESG', 0.2211962640285492)","('NON-ESG', 0.20486527681350708)","('NON-ESG', 0.1589866727590561)"
Line 56,"We  are committed to delivering positive  Our cash position remains strong  with a year-end cash and marketable  securities position of $4.4 billion,  enabling us to increase our dividend rate  by 10.6 percent for the January 2020  payment.
","('Systemic_Risk_Management', 0.80487060546875)","('Business_Model_Resilience', 0.04572803154587746)","('Competitive_Behavior', 0.036464277654886246)","(['Risk & Crisis Management'], 0.80487060546875)","('NON-ESG', 0.04572803154587746)","('NON-ESG', 0.036464277654886246)"
Line 57,"Our reported net earnings  decreased 41.4 percent, largely due to  tax benefits in 2018, and our adjusted  net earnings grew by 13.0 percent.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3862352967262268)","('Systemic_Risk_Management', 0.19841799139976501)","('Labor_Practices', 0.05306217074394226)","('NON-ESG', 0.3862352967262268)","('NON-ESG', 0.19841799139976501)","('NON-ESG', 0.05306217074394226)"
Line 58,"Innovation We continue to drive innovation through  R&D and acquisitions with a steady  stream of new product introductions  and closed several deals in the year.
","('Product_Design_And_Lifecycle_Management', 0.9443218111991882)","('Customer_Welfare', 0.007863114587962627)","('Product_Quality_And_Safety', 0.006368044298142195)","(['Product Stewardship'], 0.9443218111991882)","('NON-ESG', 0.007863114587962627)","('NON-ESG', 0.006368044298142195)"
Line 59,"In addition, we signed a definitive  agreement to acquire Wright Medical for approximately $5.4 billion (including  convertible debt), which is expected to  close in the second half of 2020.
","('Systemic_Risk_Management', 0.43156933784484863)","('Business_Model_Resilience', 0.22893036901950836)","('Management_Of_Legal_And_Regulatory_Framework', 0.06558454781770706)","('NON-ESG', 0.43156933784484863)","('NON-ESG', 0.22893036901950836)","('NON-ESG', 0.06558454781770706)"
Line 60,"This  acquisition should add nearly $1 billion  of revenue to our fast-growing Trauma  & Extremities business.
","('Business_Model_Resilience', 0.6134339570999146)","('Systemic_Risk_Management', 0.13605010509490967)","('Supply_Chain_Management', 0.024896735325455666)","(['Codes of Business Conduct'], 0.6134339570999146)","('NON-ESG', 0.13605010509490967)","('NON-ESG', 0.024896735325455666)"
Line 61,"Cost transformation We remain committed to systematically  reducing costs to enable growth.
","('Energy_Management', 0.4516052007675171)","('Supply_Chain_Management', 0.08786877244710922)","('Systemic_Risk_Management', 0.08348314464092255)","('NON-ESG', 0.4516052007675171)","('NON-ESG', 0.08786877244710922)","('NON-ESG', 0.08348314464092255)"
Line 62,"We  were pleased to deliver 40 basis points  of adjusted operating margin expansion  in 2019 despite significant dilution  from acquisitions.
","('Systemic_Risk_Management', 0.4052053391933441)","('Business_Model_Resilience', 0.2432040274143219)","('Competitive_Behavior', 0.09553806483745575)","('NON-ESG', 0.4052053391933441)","('NON-ESG', 0.2432040274143219)","('NON-ESG', 0.09553806483745575)"
Line 63,"We successfully  implemented a large-scale enterprise  resource planning (ERP) deployment  at our Instruments division and are Billions 2019$14.9B $0$1$2$3$4$5$6$7$8$9$10$11$12$13$14$15History of net sales growth Straight years of   sales growth 16.2% CAGR in net sales   over 40-year   periodStryker | 2019 Annual Review  2019 acquisitions:   growth opportunities and   market-leading  innovations  With a disciplined approach, Stryker strategically acquires  businesses and integrates them quickly to accelerate long-term  growth opportunities in both existing and new segments of  our industry.
","('Business_Model_Resilience', 0.6349890232086182)","('Systemic_Risk_Management', 0.11863453686237335)","('Supply_Chain_Management', 0.03880263492465019)","(['Codes of Business Conduct'], 0.6349890232086182)","('NON-ESG', 0.11863453686237335)","('NON-ESG', 0.03880263492465019)"
Line 64,"We successfully  implemented a large-scale enterprise  resource planning (ERP) deployment  at our Instruments division and are Billions 2019$14.9B $0$1$2$3$4$5$6$7$8$9$10$11$12$13$14$15History of net sales growth Straight years of   sales growth 16.2% CAGR in net sales   over 40-year   periodStryker | 2019 Annual Review  2019 acquisitions:   growth opportunities and   market-leading  innovations  With a disciplined approach, Stryker strategically acquires  businesses and integrates them quickly to accelerate long-term  growth opportunities in both existing and new segments of  our industry.
","('Business_Model_Resilience', 0.7254647612571716)","('Systemic_Risk_Management', 0.06828538328409195)","('Supply_Chain_Management', 0.048069242388010025)","(['Codes of Business Conduct'], 0.7254647612571716)","('NON-ESG', 0.06828538328409195)","('NON-ESG', 0.048069242388010025)"
Line 65,"In 2019, we completed four acquisitions that will  bring innovative and complementary products to our portfolio  and strengthen our market leadership.
","('Product_Design_And_Lifecycle_Management', 0.9615408182144165)","('Customer_Welfare', 0.004735684487968683)","('Product_Quality_And_Safety', 0.003964642528444529)","(['Product Stewardship'], 0.9615408182144165)","('NON-ESG', 0.004735684487968683)","('NON-ESG', 0.003964642528444529)"
Line 66,"Arrinex Based in Menlo Park, California, Arrinex developed ClariFix, a novel  cryoablation technology for the treatment of chronic rhinitis.
","('Employee_Health_And_Safety', 0.3117167353630066)","('Product_Quality_And_Safety', 0.10189098119735718)","('Business_Ethics', 0.056734178215265274)","('NON-ESG', 0.3117167353630066)","('NON-ESG', 0.10189098119735718)","('NON-ESG', 0.056734178215265274)"
Line 67,"This  condition, which affects more than 24 million people in the U.S. each  year, may cause runny nose, congestion, sneezing and nasal itching.
","('Employee_Health_And_Safety', 0.8522040247917175)","('Employee_Engagement_Inclusion_And_Diversity', 0.017273778095841408)","('Waste_And_Hazardous_Materials_Management', 0.015392485074698925)","(['Operational Eco-Efficiency'], 0.8522040247917175)","('NON-ESG', 0.017273778095841408)","('NON-ESG', 0.015392485074698925)"
Line 68,"ClariFix complements and further expands Stryker’s Ear, Nose and  Throat (ENT) portfolio with a unique product that meets the needs of a  large, underpenetrated segment of the ENT market where we have not  competed previously.
","('Product_Design_And_Lifecycle_Management', 0.7428001165390015)","('Customer_Welfare', 0.09399732947349548)","('Product_Quality_And_Safety', 0.02907388098537922)","(['Product Stewardship'], 0.7428001165390015)","('NON-ESG', 0.09399732947349548)","('NON-ESG', 0.02907388098537922)"
Line 69,"As a result, ENT physicians have new technologies  that deliver more treatment options and better patient outcomes.Stryker | 2019 Annual Review  OrthoSpace With the acquisition of Israel-based OrthoSpace,  we have added to our sports medicine portfolio a  highly differentiated technology for the treatment  of massive rotator cuff tears.
","('Employee_Health_And_Safety', 0.6328086853027344)","('Access_And_Affordability', 0.04835538938641548)","('Employee_Engagement_Inclusion_And_Diversity', 0.04424078390002251)","(['Operational Eco-Efficiency'], 0.6328086853027344)","('NON-ESG', 0.04835538938641548)","('NON-ESG', 0.04424078390002251)"
Line 70,"Called InSpace, the  product is a biodegradable sub-acromial spacer,  which is designed to realign the natural biomechanics  of the shoulder.
","('Product_Design_And_Lifecycle_Management', 0.8477386832237244)","('Energy_Management', 0.024818183854222298)","('Customer_Welfare', 0.02257910743355751)","(['Product Stewardship'], 0.8477386832237244)","('NON-ESG', 0.024818183854222298)","('NON-ESG', 0.02257910743355751)"
Line 71,"InSpace has a clinical history of more  than 20,000 patients being treated in 30 countries  and provides our customers an innovative surgical  option to address a complex pathology.
","('Access_And_Affordability', 0.18211349844932556)","('Customer_Welfare', 0.14839406311511993)","('Employee_Health_And_Safety', 0.10336659103631973)","('NON-ESG', 0.18211349844932556)","('NON-ESG', 0.14839406311511993)","('NON-ESG', 0.10336659103631973)"
Line 72,"The InSpace  device is currently investigational and not approved  for sale in the U.S. and limited by Federal law to  clinical investigational use.Mobius Imaging and   Cardan Robotics With expertise in advanced imaging and robotics, as  well as a robust product pipeline, Mobius Imaging  and Cardan Robotics will strengthen our presence in  our key Orthopaedics, Spine and Neurotechnology  markets.
","('Customer_Welfare', 0.28604286909103394)","('Product_Design_And_Lifecycle_Management', 0.26116734743118286)","('Product_Quality_And_Safety', 0.11457224935293198)","('NON-ESG', 0.28604286909103394)","('NON-ESG', 0.26116734743118286)","('NON-ESG', 0.11457224935293198)"
Line 73,"As a result, we are positioned to make  healthcare better by providing more complete  procedural solutions, including sales, service, and  support, while helping surgeons achieve the best  possible outcomes for their patients.
","('Access_And_Affordability', 0.41585955023765564)","('Customer_Welfare', 0.10885713994503021)","('Product_Design_And_Lifecycle_Management', 0.06377383321523666)","('NON-ESG', 0.41585955023765564)","('NON-ESG', 0.10885713994503021)","('NON-ESG', 0.06377383321523666)"
Line 74,"SafeAir This Swiss medical device company designs, develops  and manufactures innovative surgical smoke evacuation  products that help reduce staff and patient exposure  to hazards associated with surgical smoke.
","('Employee_Health_And_Safety', 0.7510876059532166)","('Air_Quality', 0.05540475621819496)","('Waste_And_Hazardous_Materials_Management', 0.03905989229679108)","(['Operational Eco-Efficiency'], 0.7510876059532166)","('NON-ESG', 0.05540475621819496)","('NON-ESG', 0.03905989229679108)"
Line 75,"Highly  complementary to our Surgical Technologies business,  SafeAir products strengthen our existing smoke evacuation  portfolio in both the U.S. and Europe and align with our  goal of providing better care and a higher level of safety  for both healthcare professionals and patients.
","('Product_Quality_And_Safety', 0.6845151782035828)","('Product_Design_And_Lifecycle_Management', 0.09448645263910294)","('Employee_Health_And_Safety', 0.06444419175386429)","(['Product Quality & Recall Management'], 0.6845151782035828)","('NON-ESG', 0.09448645263910294)","('NON-ESG', 0.06444419175386429)"
Line 76,"Stryker | 2019 Annual Review  Mako expands reach  in Asia Pacific Thanks to its demonstrated accuracy  and precision1–5 and a concerted  marketing effort, Mako enjoyed  significant growth in Asia Pacific in  2019.
","('Customer_Welfare', 0.322464257478714)","('Product_Design_And_Lifecycle_Management', 0.18300920724868774)","('Competitive_Behavior', 0.09447645395994186)","('NON-ESG', 0.322464257478714)","('NON-ESG', 0.18300920724868774)","('NON-ESG', 0.09447645395994186)"
Line 77,"Two key reasons for this growth  were the acceleration of China’s Mako  Total Hip joint replacement business  since it was introduced in 2018, and the  2019 launch of Mako Total Hip and Total  Knee in Japan.
","('Employee_Health_And_Safety', 0.8777077198028564)","('Employee_Engagement_Inclusion_And_Diversity', 0.012996703386306763)","('Critical_Incident_Risk_Management', 0.009515304118394852)","(['Operational Eco-Efficiency'], 0.8777077198028564)","('NON-ESG', 0.012996703386306763)","('NON-ESG', 0.009515304118394852)"
Line 78,"In both of these large markets, Stryker  emphasized clinical evidence, training  and education, and media awareness  to support this growth.
","('Access_And_Affordability', 0.4914906919002533)","('Management_Of_Legal_And_Regulatory_Framework', 0.1190035417675972)","('Product_Quality_And_Safety', 0.053549833595752716)","('NON-ESG', 0.4914906919002533)","('NON-ESG', 0.1190035417675972)","('NON-ESG', 0.053549833595752716)"
Line 79,"“Because we  have been helping surgeons to know  more about a patient’s unique anatomy  with Mako SmartRobotics™ CT-based  planning, and accurately and precisely1–5  cut less6–10 with AccuStop™ haptic  technology, healthcare professionals are  welcoming Mako with open arms,” says  Christopher Roger, Director, Robotics  Sales and Support, Japan.
","('Employee_Health_And_Safety', 0.3801150918006897)","('Employee_Engagement_Inclusion_And_Diversity', 0.10759569704532623)","('Product_Design_And_Lifecycle_Management', 0.10456967353820801)","('NON-ESG', 0.3801150918006897)","('NON-ESG', 0.10759569704532623)","('NON-ESG', 0.10456967353820801)"
Line 80,"In both countries, the number of  Mako systems and procedures has  increased significantly.
","('Business_Ethics', 0.209448903799057)","('Management_Of_Legal_And_Regulatory_Framework', 0.1598862111568451)","('Employee_Health_And_Safety', 0.09236074239015579)","('NON-ESG', 0.209448903799057)","('NON-ESG', 0.1598862111568451)","('NON-ESG', 0.09236074239015579)"
Line 81,"In Japan, for  example, the growth opportunities  are considerable.
","('Business_Model_Resilience', 0.3680913746356964)","('Systemic_Risk_Management', 0.3298969268798828)","('Competitive_Behavior', 0.05371494218707085)","('NON-ESG', 0.3680913746356964)","('NON-ESG', 0.3298969268798828)","('NON-ESG', 0.05371494218707085)"
Line 82,"Approximately  60,000 total hip replacements  and 82,000 total knee and partial  knee replacements are performed  annually,11 with the number  expected to increase due to the aging  population.
","('Employee_Health_And_Safety', 0.8883594870567322)","('Employee_Engagement_Inclusion_And_Diversity', 0.024854430928826332)","('Ecological_Impacts', 0.009825640358030796)","(['Operational Eco-Efficiency'], 0.8883594870567322)","('NON-ESG', 0.024854430928826332)","('NON-ESG', 0.009825640358030796)"
Line 83,"Stryker has sponsored  trainings and participated in surgical  conferences and events in Asia  Pacific to educate surgeons on the  use of Mako technology.
","('Product_Design_And_Lifecycle_Management', 0.23593753576278687)","('Employee_Health_And_Safety', 0.11233676224946976)","('Energy_Management', 0.10817701369524002)","('NON-ESG', 0.23593753576278687)","('NON-ESG', 0.11233676224946976)","('NON-ESG', 0.10817701369524002)"
Line 84,"A Mako media day in Japan, which  focused on innovations in joint  replacement surgeries, resulted in  local and industry news stories that  reached more than 30 million people.
","('Employee_Health_And_Safety', 0.40612778067588806)","('Access_And_Affordability', 0.14381642639636993)","('Product_Quality_And_Safety', 0.06629464030265808)","('NON-ESG', 0.40612778067588806)","('NON-ESG', 0.14381642639636993)","('NON-ESG', 0.06629464030265808)"
Line 85,"See references on page 21.©Kobe Kaisei Hospital“ In my experience, Mako Total Hip  has shown better outcomes after  surgery compared to arthroplasty  performed manually.1”   — Dr. Nao Shibanuma,   Deputy Medical Director,  Kobe Kaisei Hospital  The first hospital to install Mako in JapanStryker | 2019 Annual Review  Making   healthcare better   with medical educationAlong with our commitment to  delivering innovative and industry- leading technology, Stryker provides  extensive medical education and training  offerings for healthcare professionals.
","('Employee_Health_And_Safety', 0.43114766478538513)","('Access_And_Affordability', 0.27256470918655396)","('Employee_Engagement_Inclusion_And_Diversity', 0.05787283554673195)","('NON-ESG', 0.43114766478538513)","('NON-ESG', 0.27256470918655396)","('NON-ESG', 0.05787283554673195)"
Line 86,"See references on page 21.©Kobe Kaisei Hospital“ In my experience, Mako Total Hip  has shown better outcomes after  surgery compared to arthroplasty  performed manually.1”   — Dr. Nao Shibanuma,   Deputy Medical Director,  Kobe Kaisei Hospital  The first hospital to install Mako in JapanStryker | 2019 Annual Review  Making   healthcare better   with medical educationAlong with our commitment to  delivering innovative and industry- leading technology, Stryker provides  extensive medical education and training  offerings for healthcare professionals.
","('Access_And_Affordability', 0.4277600049972534)","('Employee_Engagement_Inclusion_And_Diversity', 0.1673765778541565)","('Customer_Welfare', 0.05304739251732826)","('NON-ESG', 0.4277600049972534)","('NON-ESG', 0.1673765778541565)","('NON-ESG', 0.05304739251732826)"
Line 87,"These offerings are designed to help  advance product and procedural  knowledge and skills, improve customer  competence and confidence, and lead to  better patient outcomes.
","('Employee_Engagement_Inclusion_And_Diversity', 0.31028327345848083)","('Access_And_Affordability', 0.11231230199337006)","('Product_Design_And_Lifecycle_Management', 0.0905686765909195)","('NON-ESG', 0.31028327345848083)","('NON-ESG', 0.11231230199337006)","('NON-ESG', 0.0905686765909195)"
Line 88,"Here are some  highlights from across the company: Craniomaxillofacial (CMF) Our CMF medical education programs  include national, regional and local  courses for neurosurgeons and  craniomaxillofacial surgeons who  perform trauma, reconstructive and  orthognathic (jaw) surgery.
","('Employee_Health_And_Safety', 0.8738642930984497)","('Employee_Engagement_Inclusion_And_Diversity', 0.03330136090517044)","('Access_And_Affordability', 0.008864155039191246)","(['Operational Eco-Efficiency'], 0.8738642930984497)","('NON-ESG', 0.03330136090517044)","('NON-ESG', 0.008864155039191246)"
Line 89,"Many  courses include a cadaveric component  taught by surgeons who are leaders  in their field, providing an elevated,  hands-on experience for attendees.
","('Employee_Engagement_Inclusion_And_Diversity', 0.41614240407943726)","('Access_And_Affordability', 0.13279487192630768)","('Employee_Health_And_Safety', 0.05002163350582123)","('NON-ESG', 0.41614240407943726)","('NON-ESG', 0.13279487192630768)","('NON-ESG', 0.05002163350582123)"
Line 90,"We  also emphasize personalized medicine  through education on the use of virtual  surgical planning and other patient- specific surgical solutions that support  improving patient outcomes.
","('Access_And_Affordability', 0.39925748109817505)","('Employee_Health_And_Safety', 0.25424861907958984)","('Customer_Welfare', 0.060256149619817734)","('NON-ESG', 0.39925748109817505)","('NON-ESG', 0.25424861907958984)","('NON-ESG', 0.060256149619817734)"
Line 91,"On-demand  education is also offered online through  our surgical video library.
","('Access_And_Affordability', 0.6272332668304443)","('Management_Of_Legal_And_Regulatory_Framework', 0.050806161016225815)","('Energy_Management', 0.047647155821323395)","(['Health Outcome Contribution'], 0.6272332668304443)","('NON-ESG', 0.050806161016225815)","('NON-ESG', 0.047647155821323395)"
Line 92,"Endoscopy With our industry-leading SPY imaging  technology, we established a training  program to help drive the adoption  of fluorescence as a standard of care.
","('Energy_Management', 0.5232045650482178)","('Customer_Welfare', 0.07042641937732697)","('Product_Design_And_Lifecycle_Management', 0.06512872874736786)","(['Operational Eco-Efficiency'], 0.5232045650482178)","('NON-ESG', 0.07042641937732697)","('NON-ESG', 0.06512872874736786)"
Line 93,"Our popular iSPIES program covers colorectal, uro-gynecological, pediatric  cardiovascular and cardiothoracic  procedures.
","('Access_And_Affordability', 0.31472161412239075)","('Employee_Health_And_Safety', 0.1856929212808609)","('Employee_Engagement_Inclusion_And_Diversity', 0.10434433817863464)","('NON-ESG', 0.31472161412239075)","('NON-ESG', 0.1856929212808609)","('NON-ESG', 0.10434433817863464)"
Line 94,"From symposiums to  clinical immersion, we offer customized  education, including a fellows  textbook program and courses, surgery  observation programs and regional  trainings so surgeons can avoid travel.
","('Access_And_Affordability', 0.4191027879714966)","('Employee_Engagement_Inclusion_And_Diversity', 0.17000117897987366)","('Employee_Health_And_Safety', 0.05414247140288353)","('NON-ESG', 0.4191027879714966)","('NON-ESG', 0.17000117897987366)","('NON-ESG', 0.05414247140288353)"
Line 95,"Joint Replacement A wide variety of programs are available  for joint replacement surgeons,  including the highly attended Mako  System Certification program.
","('Employee_Health_And_Safety', 0.9296389222145081)","('Employee_Engagement_Inclusion_And_Diversity', 0.01569499634206295)","('Product_Quality_And_Safety', 0.005849511828273535)","(['Operational Eco-Efficiency'], 0.9296389222145081)","('NON-ESG', 0.01569499634206295)","('NON-ESG', 0.005849511828273535)"
Line 96,"During  this comprehensive hands-on program,  surgeons must successfully complete  two cadaveric joints with each Mako  application in order to be certified to  perform Mako procedures.
","('Employee_Health_And_Safety', 0.739011824131012)","('Employee_Engagement_Inclusion_And_Diversity', 0.04790870472788811)","('Access_And_Affordability', 0.038093019276857376)","(['Operational Eco-Efficiency'], 0.739011824131012)","('NON-ESG', 0.04790870472788811)","('NON-ESG', 0.038093019276857376)"
Line 97,"Other in- demand educational offerings are our  Virtual Surgical Demos and Observations  live events, broadcasted to surgeons and  OR staff, in which Mako robotic-arm  assisted procedures are demonstrated.
","('Employee_Health_And_Safety', 0.6893892884254456)","('Access_And_Affordability', 0.05921555683016777)","('Employee_Engagement_Inclusion_And_Diversity', 0.05004718154668808)","(['Operational Eco-Efficiency'], 0.6893892884254456)","('NON-ESG', 0.05921555683016777)","('NON-ESG', 0.05004718154668808)"
Line 98,"We also have surgical simulations on  both the Mako Partial Knee and Mako  Total Knee, which allow surgeons to  practice intra-operative balancing at  their own pace.
","('Employee_Health_And_Safety', 0.80939120054245)","('Access_And_Affordability', 0.019651470705866814)","('Employee_Engagement_Inclusion_And_Diversity', 0.01848813146352768)","(['Operational Eco-Efficiency'], 0.80939120054245)","('NON-ESG', 0.019651470705866814)","('NON-ESG', 0.01848813146352768)"
Line 99,"Neurosurgical  In our Stryker Training Center in Salt  Lake City, Utah, neurosurgery residents  can take the Neurotechnology National  Course, drawing on the wisdom of world- renowned faculty members.
","('Access_And_Affordability', 0.3008686304092407)","('Employee_Health_And_Safety', 0.2583554685115814)","('Employee_Engagement_Inclusion_And_Diversity', 0.09864603728055954)","('NON-ESG', 0.3008686304092407)","('NON-ESG', 0.2583554685115814)","('NON-ESG', 0.09864603728055954)"
Line 100,"2019 marked  the first annual cross-divisional program Stryker | 2019 Annual Review  that covered our entire Neurotechnology  portfolio, including Spine, Interventional  Spine, Neurosurgical, CMF and  Neurovascular.
","('Employee_Health_And_Safety', 0.3522629141807556)","('Access_And_Affordability', 0.1649136245250702)","('Employee_Engagement_Inclusion_And_Diversity', 0.10555119812488556)","('NON-ESG', 0.3522629141807556)","('NON-ESG', 0.1649136245250702)","('NON-ESG', 0.10555119812488556)"
Line 101,"We also offer a hands-on  National OR Professional Workshop for  operating room directors, coordinators,  RNs, scrub techs and sterile processing  professionals.
","('Waste_And_Hazardous_Materials_Management', 0.7194489240646362)","('Water_And_Wastewater_Management', 0.07189946621656418)","('Employee_Health_And_Safety', 0.03150855377316475)","(['Operational Eco-Efficiency'], 0.7194489240646362)","('NON-ESG', 0.07189946621656418)","('NON-ESG', 0.03150855377316475)"
Line 102,"In 2019 our Mobile Lab,  which simulates eight operating rooms,  hosted 140 events across the country.
","('Management_Of_Legal_And_Regulatory_Framework', 0.14043021202087402)","('Business_Model_Resilience', 0.08210553973913193)","('Energy_Management', 0.07197139412164688)","('NON-ESG', 0.14043021202087402)","('NON-ESG', 0.08210553973913193)","('NON-ESG', 0.07197139412164688)"
Line 103,"Neurovascular Stroke Knowledge Initiatives for  Learning and Leadership (SKILL) is a  series of innovative, tailored ischemic  and hemorrhagic stroke education  programs that support our customers’  need to address patient management  challenges with the ultimate shared  goal of improving lives.
","('Access_And_Affordability', 0.5379055142402649)","('Employee_Health_And_Safety', 0.09021612256765366)","('Employee_Engagement_Inclusion_And_Diversity', 0.055733565241098404)","(['Health Outcome Contribution'], 0.5379055142402649)","('NON-ESG', 0.09021612256765366)","('NON-ESG', 0.055733565241098404)"
Line 104,"SKILL features  an e-lab, NeuroElite fellows program,  training center initiatives and global  centers of excellence.
","('Access_And_Affordability', 0.3552438020706177)","('Employee_Engagement_Inclusion_And_Diversity', 0.21950912475585938)","('Ecological_Impacts', 0.04919138923287392)","('NON-ESG', 0.3552438020706177)","('NON-ESG', 0.21950912475585938)","('NON-ESG', 0.04919138923287392)"
Line 105,"Orthopaedic Instruments  and Surgical Technologies Through Stryker’s Learn Program,  operating room professionals have  access to industry resources designed  to enhance the understanding and  use of various medical technologies.
","('Product_Design_And_Lifecycle_Management', 0.2882641553878784)","('Access_And_Affordability', 0.19652330875396729)","('Customer_Welfare', 0.07292494177818298)","('NON-ESG', 0.2882641553878784)","('NON-ESG', 0.19652330875396729)","('NON-ESG', 0.07292494177818298)"
Line 106,"With programs based on extensive  research findings and practical industry  knowledge, we are dedicated to  empowering and advancing healthcare  providers at every stage of their career.Trauma & Extremities TEACH programs (Trauma and Extremities  Academic Courses for Healthcare) include training  on the effective use of Stryker products in Trauma,  Shoulder and Foot and Ankle for the orthopaedic  surgeon community, which consists of nurses,  residents and fellows, as well as practicing surgeons.
","('Employee_Health_And_Safety', 0.9383047819137573)","('Critical_Incident_Risk_Management', 0.011082391254603863)","('Access_And_Affordability', 0.008742059580981731)","(['Operational Eco-Efficiency'], 0.9383047819137573)","('NON-ESG', 0.011082391254603863)","('NON-ESG', 0.008742059580981731)"
Line 107,"TEACH faculty are invited by Stryker to attend a  program educating them on Advanced Training  Principles to enhance their teaching skills, ultimately  contributing to the quality of the TEACH programs.
","('Access_And_Affordability', 0.47647449374198914)","('Employee_Engagement_Inclusion_And_Diversity', 0.11555998772382736)","('Product_Quality_And_Safety', 0.06572379171848297)","('NON-ESG', 0.47647449374198914)","('NON-ESG', 0.11555998772382736)","('NON-ESG', 0.06572379171848297)"
Line 108,"Launched in 2019, the Connect program provides  educational resources to residents at teaching  institutions and continues as they transition into  fellowship and practice.
","('Access_And_Affordability', 0.8252416849136353)","('Employee_Engagement_Inclusion_And_Diversity', 0.03247213736176491)","('Human_Rights_And_Community_Relations', 0.01332196407020092)","(['Health Outcome Contribution'], 0.8252416849136353)","('NON-ESG', 0.03247213736176491)","('NON-ESG', 0.01332196407020092)"
Line 109,"New initiatives such as  digital learning platforms and cross-divisional  dissection courses were introduced to expand  Stryker’s educational resources for residents and  fellows at teaching institutions.
","('Access_And_Affordability', 0.7243248224258423)","('Management_Of_Legal_And_Regulatory_Framework', 0.03816504776477814)","('Ecological_Impacts', 0.027961110696196556)","(['Health Outcome Contribution'], 0.7243248224258423)","('NON-ESG', 0.03816504776477814)","('NON-ESG', 0.027961110696196556)"
Line 110,"Stryker | 2019 Annual Review  Corporate   Responsibility At Stryker, corporate responsibility  is an important part of who we  are —  as individuals, teams and one  connected company.
","('Human_Rights_And_Community_Relations', 0.599190354347229)","('Business_Model_Resilience', 0.08259350061416626)","('Director_Removal', 0.029461780562996864)","(['Community Relations'], 0.599190354347229)","('NON-ESG', 0.08259350061416626)","('NON-ESG', 0.029461780562996864)"
Line 111,"Driven by our  shared values, it’s built into the way  we operate our company.
","('Human_Rights_And_Community_Relations', 0.5281656980514526)","('Employee_Engagement_Inclusion_And_Diversity', 0.06690343469381332)","('Business_Model_Resilience', 0.05355799198150635)","(['Community Relations'], 0.5281656980514526)","('NON-ESG', 0.06690343469381332)","('NON-ESG', 0.05355799198150635)"
Line 112,"Our mission  is to improve healthcare by working  with our customers to make the  world better for patients, caregivers,  employees and the environment.
","('Access_And_Affordability', 0.85780268907547)","('Human_Rights_And_Community_Relations', 0.025681085884571075)","('Employee_Health_And_Safety', 0.019603321328759193)","(['Health Outcome Contribution'], 0.85780268907547)","('NON-ESG', 0.025681085884571075)","('NON-ESG', 0.019603321328759193)"
Line 113,"Learn more about our commitment  to people and the planet in our  Corporate Responsibility Review at  stryker.com/CR  surgeries funded through  our Smile Match campaign  where employee donations to  Operation Smile are matched  until we reach our goal.Investing in people for stronger health, safety,  talent and inclusion  709+ 2019 achievements   through our key focus areasStryker | 2019 Annual Review  because transparency,  honesty and fairness  should always be  paramount Ethics and  accountability In 2019, our Board amended  our bylaws to implement  proxy access.
","('Business_Ethics', 0.9555851221084595)","('Human_Rights_And_Community_Relations', 0.004128653090447187)","('Management_Of_Legal_And_Regulatory_Framework', 0.0039456491358578205)","(['Business Ethics'], 0.9555851221084595)","('NON-ESG', 0.004128653090447187)","('NON-ESG', 0.0039456491358578205)"
Line 114,"Learn more about our commitment  to people and the planet in our  Corporate Responsibility Review at  stryker.com/CR  surgeries funded through  our Smile Match campaign  where employee donations to  Operation Smile are matched  until we reach our goal.Investing in people for stronger health, safety,  talent and inclusion  709+ 2019 achievements   through our key focus areasStryker | 2019 Annual Review  because transparency,  honesty and fairness  should always be  paramount Ethics and  accountability In 2019, our Board amended  our bylaws to implement  proxy access.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5278451442718506)","('Business_Ethics', 0.091078981757164)","('Competitive_Behavior', 0.08043882995843887)","(['Corporate Governance'], 0.5278451442718506)","('NON-ESG', 0.091078981757164)","('NON-ESG', 0.08043882995843887)"
Line 115,"This permits a  shareholder or a group of up  to 20 shareholders owning at  least 3 percent of Stryker’s  common stock for at least three  years, to nominate and include  in Stryker’s proxy materials  director nominees constituting  up to the greater of two  individuals or 20 percent  of the Board.Addressing the need for  compliant medical waste  disposal systems, Cactus Smart  Sink System securely captures  partially administered or  unused controlled substances  and renders them non- retrievable and unusable.
","('Waste_And_Hazardous_Materials_Management', 0.9814658164978027)","('Water_And_Wastewater_Management', 0.0025530648417770863)","('Employee_Health_And_Safety', 0.0013458870816975832)","(['Operational Eco-Efficiency'], 0.9814658164978027)","('NON-ESG', 0.0025530648417770863)","('NON-ESG', 0.0013458870816975832)"
Line 116,"This permits a  shareholder or a group of up  to 20 shareholders owning at  least 3 percent of Stryker’s  common stock for at least three  years, to nominate and include  in Stryker’s proxy materials  director nominees constituting  up to the greater of two  individuals or 20 percent  of the Board.Addressing the need for  compliant medical waste  disposal systems, Cactus Smart  Sink System securely captures  partially administered or  unused controlled substances  and renders them non- retrievable and unusable.
","('Data_Security', 0.09459661692380905)","('Product_Design_And_Lifecycle_Management', 0.0851619616150856)","('Energy_Management', 0.0838506743311882)","('NON-ESG', 0.09459661692380905)","('NON-ESG', 0.0851619616150856)","('NON-ESG', 0.0838506743311882)"
Line 117,"The system helps reduce  drug diversion and improve  patient safety while also  reducing the impact on the  environment.Product lifecycle  innovationResource efficiency carefully considering our  use of materials across a  product’s lifecyclereducing water, waste and  emissions spent with minority, women, and  veteran-owned businessessaved by customers through  reprocessing programs spent with small businessespounds of waste diverted  from landfills Responsible   supply chains managing and sourcing  suppliers with the highest  standards $225M$375.6M $700M13.4M Stryker | 2019 Annual Review  Diversity and inclusion:   we win together as a team  At Stryker, we win together as a team.
","('Waste_And_Hazardous_Materials_Management', 0.9646427035331726)","('Product_Design_And_Lifecycle_Management', 0.007495290599763393)","('Water_And_Wastewater_Management', 0.0027470376808196306)","(['Operational Eco-Efficiency'], 0.9646427035331726)","('NON-ESG', 0.007495290599763393)","('NON-ESG', 0.0027470376808196306)"
Line 118,"The system helps reduce  drug diversion and improve  patient safety while also  reducing the impact on the  environment.Product lifecycle  innovationResource efficiency carefully considering our  use of materials across a  product’s lifecyclereducing water, waste and  emissions spent with minority, women, and  veteran-owned businessessaved by customers through  reprocessing programs spent with small businessespounds of waste diverted  from landfills Responsible   supply chains managing and sourcing  suppliers with the highest  standards $225M$375.6M $700M13.4M Stryker | 2019 Annual Review  Diversity and inclusion:   we win together as a team  At Stryker, we win together as a team.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9677845239639282)","('Human_Rights_And_Community_Relations', 0.0036707636900246143)","('Employee_Health_And_Safety', 0.002338801044970751)","(['Human Capital Development'], 0.9677845239639282)","('NON-ESG', 0.0036707636900246143)","('NON-ESG', 0.002338801044970751)"
Line 119,"Our mission and values unite employees  around a diverse and inclusive culture  that delivers remarkable results.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9695411920547485)","('Human_Rights_And_Community_Relations', 0.0029926577117294073)","('Employee_Health_And_Safety', 0.0024808738380670547)","(['Human Capital Development'], 0.9695411920547485)","('NON-ESG', 0.0029926577117294073)","('NON-ESG', 0.0024808738380670547)"
Line 120,"And we  create and invest in programs that foster  a positive workplace experience.
","('Employee_Engagement_Inclusion_And_Diversity', 0.49198609590530396)","('Human_Rights_And_Community_Relations', 0.18191884458065033)","('Employee_Health_And_Safety', 0.08948785066604614)","('NON-ESG', 0.49198609590530396)","('NON-ESG', 0.18191884458065033)","('NON-ESG', 0.08948785066604614)"
Line 121,"Here  are some of our recent activities and  programs: Annual engagement   survey “We constantly challenge ourselves  to achieve more by listening to our  employees’ suggestions and taking  action to improve our workplace,”  says Cindy Carlisle, Vice President,  Talent Management and Corporate HR.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9446029663085938)","('Employee_Health_And_Safety', 0.008096396923065186)","('Product_Quality_And_Safety', 0.00401644641533494)","(['Human Capital Development'], 0.9446029663085938)","('NON-ESG', 0.008096396923065186)","('NON-ESG', 0.00401644641533494)"
Line 122,"“For more than 25 years, we’ve used  our annual company-wide employee  engagement survey to uncover and take  action on important issues affecting our  work environment.” Unconscious bias training Unconscious biases exist even in  the most open-minded people and  organizations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3604961633682251)","('Business_Ethics', 0.1334719955921173)","('Competitive_Behavior', 0.12265878170728683)","('NON-ESG', 0.3604961633682251)","('NON-ESG', 0.1334719955921173)","('NON-ESG', 0.12265878170728683)"
Line 123,"We address this  proactively through our Think Twice  course, a workshop that showcases what  bias is, how and where it shows up,  and what to do about it.
","('Competitive_Behavior', 0.41081514954566956)","('Management_Of_Legal_And_Regulatory_Framework', 0.16252808272838593)","('Business_Ethics', 0.08291967958211899)","('NON-ESG', 0.41081514954566956)","('NON-ESG', 0.16252808272838593)","('NON-ESG', 0.08291967958211899)"
Line 124,"Since launch,  more than 4,000 employees across  16 countries have participated in the  training, including our CEO and our  entire senior leadership team.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7525947690010071)","('Business_Model_Resilience', 0.04443150386214256)","('Human_Rights_And_Community_Relations', 0.022383442148566246)","(['Human Capital Development'], 0.7525947690010071)","('NON-ESG', 0.04443150386214256)","('NON-ESG', 0.022383442148566246)"
Line 125,"Focus groups To enhance our efforts to build an  inclusive, engaging work environment,  we partnered with a global management  consortium to conduct conversations with  employees aimed at expanding existing  initiatives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8296220302581787)","('Labor_Practices', 0.025643421337008476)","('Employee_Health_And_Safety', 0.025236794725060463)","(['Human Capital Development'], 0.8296220302581787)","('NON-ESG', 0.025643421337008476)","('NON-ESG', 0.025236794725060463)"
Line 126,"“ Attendees provided their  insights and pointed out opportunities to increase our diverse talent pipeline,”  says Cindy Carlisle.
","('Employee_Engagement_Inclusion_And_Diversity', 0.96213698387146)","('Business_Model_Resilience', 0.0031091603450477123)","('Employee_Health_And_Safety', 0.002748707542195916)","(['Human Capital Development'], 0.96213698387146)","('NON-ESG', 0.0031091603450477123)","('NON-ESG', 0.002748707542195916)"
Line 127,"“We used their  feedback to develop an actionable set  of recommendations to enhance our  Diversity and Inclusion strategy.” Diversity and Inclusion  conference To continue strengthening employee  engagement, we host inclusion  conferences.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9755406975746155)","('Employee_Health_And_Safety', 0.002236134372651577)","('Human_Rights_And_Community_Relations', 0.0016453223070129752)","(['Human Capital Development'], 0.9755406975746155)","('NON-ESG', 0.002236134372651577)","('NON-ESG', 0.0016453223070129752)"
Line 128,"Our annual inclusion  awareness conference, for example,  brings together leaders and employees  from our five campuses in Kalamazoo,  Michigan.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9608415365219116)","('Employee_Health_And_Safety', 0.006228461861610413)","('Human_Rights_And_Community_Relations', 0.00307332631200552)","(['Human Capital Development'], 0.9608415365219116)","('NON-ESG', 0.006228461861610413)","('NON-ESG', 0.00307332631200552)"
Line 129,"This full-day conference  focuses on why inclusion matters and  equips participants with tools to build a  more inclusive environment.Disabilities program in  Ireland  Patrick O’Brien, an associate at  Stryker’s Anngrove facility in Cork,  recalled a former co-worker at a  previous job who faced some tough  employment challenges because he  was deaf.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9477124214172363)","('Employee_Health_And_Safety', 0.007840101607143879)","('Human_Rights_And_Community_Relations', 0.006560381036251783)","(['Human Capital Development'], 0.9477124214172363)","('NON-ESG', 0.007840101607143879)","('NON-ESG', 0.006560381036251783)"
Line 130,"So Patrick got involved  in developing a Stryker team under  the name of ABLE — the Ability and  Belief to Leverage Everyone.
","('Employee_Engagement_Inclusion_And_Diversity', 0.26835015416145325)","('Competitive_Behavior', 0.11003226786851883)","('Business_Ethics', 0.10351212322711945)","('NON-ESG', 0.26835015416145325)","('NON-ESG', 0.11003226786851883)","('NON-ESG', 0.10351212322711945)"
Line 131,"And  over the past two years, the team  accomplished a great deal, including: • Hiring individuals with hearing  impairments • Installing pocket-sized vibrating  alarm systems for hearing- impaired people  • Modifying entranceways, desks,  coffee stations and dining tables  for people in wheelchairs • Working with the local university  on a mentorship program for  students with disabilities Stryker | 2019 Annual Review  Best Workplaces   International #1 for Australia, 2019   recipient for the sixth consecutive year Mexico, 2019   recipient for the sixth timeFORTUNE Best  Workplaces (U.S.) For Diversity, 2019   #1 out of 100 companies — recipient for  the third consecutive year For Women, 2019  #47 — recipient for the third time Best Workplaces  in Europe #14  recipient for the first timeFORTUNE 500   Largest U.S.-Based   Companies #233 in 2019  joined the list in 2003  — recipient for  the 17th consecutive yearFORTUNE 100  Best Companies to  Work For (U.S.) #8 in 2020  recipient for the tenth   consecutive yearFORTUNE World’s  Best Workplaces #8 in 2019  out of 25 companies —   recipient for the third time Women’s Choice Awards 2020 awards   named to two lists:  100 Best Workplaces for Women  Best Companies for DiversityGlobal   recognition Italy, 2019   recipient for the first time Spain, 2019  recipient for the fourth time UK, 2019  recipient for the first time  Brazil, 2019  recipient for the sixth consecutive year Canada, 2019  recipient for the tenth consecutive year Greater China, 2019  recipient for the third year France, 2019  recipient for the second consecutive year Japan, 2019  recipient for the second consecutive year Korea, 2019  recipient for the second consecutive yearFORTUNE World’s   Most Admired   Companies #5 in 2020  Medical Products and Equipment   recipient for the 18th consecutive yearStryker | 2019 Annual Review  172.004.006.008.0010.2019 20145.2.004.006.008.0010.2019 20148.0.51.01.52.02.2019 20142.08Adjusted net earnings $ Per diluted share Dividends paid $ Per share of common stockNet earnings $ Per diluted shareFinancial overview ($ in millions, except per share amounts)Financial   highlights 2019 2018 % Change Net sales $14,884 $13,601 9.4% Earnings before income taxes  2,562 2,356 8.7% Income taxes  479 (1,197) NM Net earnings  2,083 3,553 (41.4)% Adjusted net earnings1 3,139 2,779 13.0% Net earnings per diluted share  of common stock   Reported  $5.48 $9.34 (41.3)%   Adjusted1 8.26 7.31 13.0% Dividends paid per share of  common stock $2.08 $1.88 10.6% Cash, cash equivalents and  marketable securities 4,425 3,699 19.6% 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3991354703903198)","('Employee_Health_And_Safety', 0.3109411597251892)","('Access_And_Affordability', 0.08414202928543091)","('NON-ESG', 0.3991354703903198)","('NON-ESG', 0.3109411597251892)","('NON-ESG', 0.08414202928543091)"
Line 132,"And  over the past two years, the team  accomplished a great deal, including: • Hiring individuals with hearing  impairments • Installing pocket-sized vibrating  alarm systems for hearing- impaired people  • Modifying entranceways, desks,  coffee stations and dining tables  for people in wheelchairs • Working with the local university  on a mentorship program for  students with disabilities Stryker | 2019 Annual Review  Best Workplaces   International #1 for Australia, 2019   recipient for the sixth consecutive year Mexico, 2019   recipient for the sixth timeFORTUNE Best  Workplaces (U.S.) For Diversity, 2019   #1 out of 100 companies — recipient for  the third consecutive year For Women, 2019  #47 — recipient for the third time Best Workplaces  in Europe #14  recipient for the first timeFORTUNE 500   Largest U.S.-Based   Companies #233 in 2019  joined the list in 2003  — recipient for  the 17th consecutive yearFORTUNE 100  Best Companies to  Work For (U.S.) #8 in 2020  recipient for the tenth   consecutive yearFORTUNE World’s  Best Workplaces #8 in 2019  out of 25 companies —   recipient for the third time Women’s Choice Awards 2020 awards   named to two lists:  100 Best Workplaces for Women  Best Companies for DiversityGlobal   recognition Italy, 2019   recipient for the first time Spain, 2019  recipient for the fourth time UK, 2019  recipient for the first time  Brazil, 2019  recipient for the sixth consecutive year Canada, 2019  recipient for the tenth consecutive year Greater China, 2019  recipient for the third year France, 2019  recipient for the second consecutive year Japan, 2019  recipient for the second consecutive year Korea, 2019  recipient for the second consecutive yearFORTUNE World’s   Most Admired   Companies #5 in 2020  Medical Products and Equipment   recipient for the 18th consecutive yearStryker | 2019 Annual Review  172.004.006.008.0010.2019 20145.2.004.006.008.0010.2019 20148.0.51.01.52.02.2019 20142.08Adjusted net earnings $ Per diluted share Dividends paid $ Per share of common stockNet earnings $ Per diluted shareFinancial overview ($ in millions, except per share amounts)Financial   highlights 2019 2018 % Change Net sales $14,884 $13,601 9.4% Earnings before income taxes  2,562 2,356 8.7% Income taxes  479 (1,197) NM Net earnings  2,083 3,553 (41.4)% Adjusted net earnings1 3,139 2,779 13.0% Net earnings per diluted share  of common stock   Reported  $5.48 $9.34 (41.3)%   Adjusted1 8.26 7.31 13.0% Dividends paid per share of  common stock $2.08 $1.88 10.6% Cash, cash equivalents and  marketable securities 4,425 3,699 19.6% 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9614650011062622)","('Employee_Health_And_Safety', 0.003723369212821126)","('Human_Rights_And_Community_Relations', 0.0033088678028434515)","(['Human Capital Development'], 0.9614650011062622)","('NON-ESG', 0.003723369212821126)","('NON-ESG', 0.0033088678028434515)"
Line 133,"And  over the past two years, the team  accomplished a great deal, including: • Hiring individuals with hearing  impairments • Installing pocket-sized vibrating  alarm systems for hearing- impaired people  • Modifying entranceways, desks,  coffee stations and dining tables  for people in wheelchairs • Working with the local university  on a mentorship program for  students with disabilities Stryker | 2019 Annual Review  Best Workplaces   International #1 for Australia, 2019   recipient for the sixth consecutive year Mexico, 2019   recipient for the sixth timeFORTUNE Best  Workplaces (U.S.) For Diversity, 2019   #1 out of 100 companies — recipient for  the third consecutive year For Women, 2019  #47 — recipient for the third time Best Workplaces  in Europe #14  recipient for the first timeFORTUNE 500   Largest U.S.-Based   Companies #233 in 2019  joined the list in 2003  — recipient for  the 17th consecutive yearFORTUNE 100  Best Companies to  Work For (U.S.) #8 in 2020  recipient for the tenth   consecutive yearFORTUNE World’s  Best Workplaces #8 in 2019  out of 25 companies —   recipient for the third time Women’s Choice Awards 2020 awards   named to two lists:  100 Best Workplaces for Women  Best Companies for DiversityGlobal   recognition Italy, 2019   recipient for the first time Spain, 2019  recipient for the fourth time UK, 2019  recipient for the first time  Brazil, 2019  recipient for the sixth consecutive year Canada, 2019  recipient for the tenth consecutive year Greater China, 2019  recipient for the third year France, 2019  recipient for the second consecutive year Japan, 2019  recipient for the second consecutive year Korea, 2019  recipient for the second consecutive yearFORTUNE World’s   Most Admired   Companies #5 in 2020  Medical Products and Equipment   recipient for the 18th consecutive yearStryker | 2019 Annual Review  172.004.006.008.0010.2019 20145.2.004.006.008.0010.2019 20148.0.51.01.52.02.2019 20142.08Adjusted net earnings $ Per diluted share Dividends paid $ Per share of common stockNet earnings $ Per diluted shareFinancial overview ($ in millions, except per share amounts)Financial   highlights 2019 2018 % Change Net sales $14,884 $13,601 9.4% Earnings before income taxes  2,562 2,356 8.7% Income taxes  479 (1,197) NM Net earnings  2,083 3,553 (41.4)% Adjusted net earnings1 3,139 2,779 13.0% Net earnings per diluted share  of common stock   Reported  $5.48 $9.34 (41.3)%   Adjusted1 8.26 7.31 13.0% Dividends paid per share of  common stock $2.08 $1.88 10.6% Cash, cash equivalents and  marketable securities 4,425 3,699 19.6% 1.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9590041637420654)","('Human_Rights_And_Community_Relations', 0.004268616437911987)","('Business_Model_Resilience', 0.0034955700393766165)","(['Human Capital Development'], 0.9590041637420654)","('NON-ESG', 0.004268616437911987)","('NON-ESG', 0.0034955700393766165)"
Line 134,"And  over the past two years, the team  accomplished a great deal, including: • Hiring individuals with hearing  impairments • Installing pocket-sized vibrating  alarm systems for hearing- impaired people  • Modifying entranceways, desks,  coffee stations and dining tables  for people in wheelchairs • Working with the local university  on a mentorship program for  students with disabilities Stryker | 2019 Annual Review  Best Workplaces   International #1 for Australia, 2019   recipient for the sixth consecutive year Mexico, 2019   recipient for the sixth timeFORTUNE Best  Workplaces (U.S.) For Diversity, 2019   #1 out of 100 companies — recipient for  the third consecutive year For Women, 2019  #47 — recipient for the third time Best Workplaces  in Europe #14  recipient for the first timeFORTUNE 500   Largest U.S.-Based   Companies #233 in 2019  joined the list in 2003  — recipient for  the 17th consecutive yearFORTUNE 100  Best Companies to  Work For (U.S.) #8 in 2020  recipient for the tenth   consecutive yearFORTUNE World’s  Best Workplaces #8 in 2019  out of 25 companies —   recipient for the third time Women’s Choice Awards 2020 awards   named to two lists:  100 Best Workplaces for Women  Best Companies for DiversityGlobal   recognition Italy, 2019   recipient for the first time Spain, 2019  recipient for the fourth time UK, 2019  recipient for the first time  Brazil, 2019  recipient for the sixth consecutive year Canada, 2019  recipient for the tenth consecutive year Greater China, 2019  recipient for the third year France, 2019  recipient for the second consecutive year Japan, 2019  recipient for the second consecutive year Korea, 2019  recipient for the second consecutive yearFORTUNE World’s   Most Admired   Companies #5 in 2020  Medical Products and Equipment   recipient for the 18th consecutive yearStryker | 2019 Annual Review  172.004.006.008.0010.2019 20145.2.004.006.008.0010.2019 20148.0.51.01.52.02.2019 20142.08Adjusted net earnings $ Per diluted share Dividends paid $ Per share of common stockNet earnings $ Per diluted shareFinancial overview ($ in millions, except per share amounts)Financial   highlights 2019 2018 % Change Net sales $14,884 $13,601 9.4% Earnings before income taxes  2,562 2,356 8.7% Income taxes  479 (1,197) NM Net earnings  2,083 3,553 (41.4)% Adjusted net earnings1 3,139 2,779 13.0% Net earnings per diluted share  of common stock   Reported  $5.48 $9.34 (41.3)%   Adjusted1 8.26 7.31 13.0% Dividends paid per share of  common stock $2.08 $1.88 10.6% Cash, cash equivalents and  marketable securities 4,425 3,699 19.6% 1.
","('Systemic_Risk_Management', 0.29076752066612244)","('Business_Model_Resilience', 0.21192596852779388)","('Competitive_Behavior', 0.16453903913497925)","('NON-ESG', 0.29076752066612244)","('NON-ESG', 0.21192596852779388)","('NON-ESG', 0.16453903913497925)"
Line 135,"And  over the past two years, the team  accomplished a great deal, including: • Hiring individuals with hearing  impairments • Installing pocket-sized vibrating  alarm systems for hearing- impaired people  • Modifying entranceways, desks,  coffee stations and dining tables  for people in wheelchairs • Working with the local university  on a mentorship program for  students with disabilities Stryker | 2019 Annual Review  Best Workplaces   International #1 for Australia, 2019   recipient for the sixth consecutive year Mexico, 2019   recipient for the sixth timeFORTUNE Best  Workplaces (U.S.) For Diversity, 2019   #1 out of 100 companies — recipient for  the third consecutive year For Women, 2019  #47 — recipient for the third time Best Workplaces  in Europe #14  recipient for the first timeFORTUNE 500   Largest U.S.-Based   Companies #233 in 2019  joined the list in 2003  — recipient for  the 17th consecutive yearFORTUNE 100  Best Companies to  Work For (U.S.) #8 in 2020  recipient for the tenth   consecutive yearFORTUNE World’s  Best Workplaces #8 in 2019  out of 25 companies —   recipient for the third time Women’s Choice Awards 2020 awards   named to two lists:  100 Best Workplaces for Women  Best Companies for DiversityGlobal   recognition Italy, 2019   recipient for the first time Spain, 2019  recipient for the fourth time UK, 2019  recipient for the first time  Brazil, 2019  recipient for the sixth consecutive year Canada, 2019  recipient for the tenth consecutive year Greater China, 2019  recipient for the third year France, 2019  recipient for the second consecutive year Japan, 2019  recipient for the second consecutive year Korea, 2019  recipient for the second consecutive yearFORTUNE World’s   Most Admired   Companies #5 in 2020  Medical Products and Equipment   recipient for the 18th consecutive yearStryker | 2019 Annual Review  172.004.006.008.0010.2019 20145.2.004.006.008.0010.2019 20148.0.51.01.52.02.2019 20142.08Adjusted net earnings $ Per diluted share Dividends paid $ Per share of common stockNet earnings $ Per diluted shareFinancial overview ($ in millions, except per share amounts)Financial   highlights 2019 2018 % Change Net sales $14,884 $13,601 9.4% Earnings before income taxes  2,562 2,356 8.7% Income taxes  479 (1,197) NM Net earnings  2,083 3,553 (41.4)% Adjusted net earnings1 3,139 2,779 13.0% Net earnings per diluted share  of common stock   Reported  $5.48 $9.34 (41.3)%   Adjusted1 8.26 7.31 13.0% Dividends paid per share of  common stock $2.08 $1.88 10.6% Cash, cash equivalents and  marketable securities 4,425 3,699 19.6% 1.
","('Systemic_Risk_Management', 0.5894282460212708)","('Competitive_Behavior', 0.07623197138309479)","('Business_Ethics', 0.05553099140524864)","(['Risk & Crisis Management'], 0.5894282460212708)","('NON-ESG', 0.07623197138309479)","('NON-ESG', 0.05553099140524864)"
Line 136,"And  over the past two years, the team  accomplished a great deal, including: • Hiring individuals with hearing  impairments • Installing pocket-sized vibrating  alarm systems for hearing- impaired people  • Modifying entranceways, desks,  coffee stations and dining tables  for people in wheelchairs • Working with the local university  on a mentorship program for  students with disabilities Stryker | 2019 Annual Review  Best Workplaces   International #1 for Australia, 2019   recipient for the sixth consecutive year Mexico, 2019   recipient for the sixth timeFORTUNE Best  Workplaces (U.S.) For Diversity, 2019   #1 out of 100 companies — recipient for  the third consecutive year For Women, 2019  #47 — recipient for the third time Best Workplaces  in Europe #14  recipient for the first timeFORTUNE 500   Largest U.S.-Based   Companies #233 in 2019  joined the list in 2003  — recipient for  the 17th consecutive yearFORTUNE 100  Best Companies to  Work For (U.S.) #8 in 2020  recipient for the tenth   consecutive yearFORTUNE World’s  Best Workplaces #8 in 2019  out of 25 companies —   recipient for the third time Women’s Choice Awards 2020 awards   named to two lists:  100 Best Workplaces for Women  Best Companies for DiversityGlobal   recognition Italy, 2019   recipient for the first time Spain, 2019  recipient for the fourth time UK, 2019  recipient for the first time  Brazil, 2019  recipient for the sixth consecutive year Canada, 2019  recipient for the tenth consecutive year Greater China, 2019  recipient for the third year France, 2019  recipient for the second consecutive year Japan, 2019  recipient for the second consecutive year Korea, 2019  recipient for the second consecutive yearFORTUNE World’s   Most Admired   Companies #5 in 2020  Medical Products and Equipment   recipient for the 18th consecutive yearStryker | 2019 Annual Review  172.004.006.008.0010.2019 20145.2.004.006.008.0010.2019 20148.0.51.01.52.02.2019 20142.08Adjusted net earnings $ Per diluted share Dividends paid $ Per share of common stockNet earnings $ Per diluted shareFinancial overview ($ in millions, except per share amounts)Financial   highlights 2019 2018 % Change Net sales $14,884 $13,601 9.4% Earnings before income taxes  2,562 2,356 8.7% Income taxes  479 (1,197) NM Net earnings  2,083 3,553 (41.4)% Adjusted net earnings1 3,139 2,779 13.0% Net earnings per diluted share  of common stock   Reported  $5.48 $9.34 (41.3)%   Adjusted1 8.26 7.31 13.0% Dividends paid per share of  common stock $2.08 $1.88 10.6% Cash, cash equivalents and  marketable securities 4,425 3,699 19.6% 1.
","('Systemic_Risk_Management', 0.2981875240802765)","('Competitive_Behavior', 0.1002071425318718)","('Management_Of_Legal_And_Regulatory_Framework', 0.0979958027601242)","('NON-ESG', 0.2981875240802765)","('NON-ESG', 0.1002071425318718)","('NON-ESG', 0.0979958027601242)"
Line 137,"Adjusted net earnings and adjusted net earnings per diluted share are non-GAAP  financial measures.
","('Systemic_Risk_Management', 0.4394316077232361)","('Management_Of_Legal_And_Regulatory_Framework', 0.1942160427570343)","('Competitive_Behavior', 0.06074884906411171)","('NON-ESG', 0.4394316077232361)","('NON-ESG', 0.1942160427570343)","('NON-ESG', 0.06074884906411171)"
Line 138,"Refer to page 21 for a reconciliation to the most directly comparable  GAAP financial measures, net earnings and net earnings per diluted share.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4667016267776489)","('Systemic_Risk_Management', 0.25570419430732727)","('Competitive_Behavior', 0.04669150710105896)","('NON-ESG', 0.4667016267776489)","('NON-ESG', 0.25570419430732727)","('NON-ESG', 0.04669150710105896)"
Line 139,"NM = Not MeaningfulStryker | 2019 Annual Review    Orthopaedics   14%7% 15% 14% 13% 2% 12%11%9%3%Medical and Surgical (M edSurg)  Neurotechnology and Spine  Leading   in medtech 12% Knees 11% Trauma & Extremities  9% Hips  3% Other35%Orthopaedics15% Medical 14% Instruments 13% Endoscopy  2% Sustainability Solutions44%MedSurg 14% Neurotechnology   7% Spine21%Neurotechnology   and Spine $14.9B in global salesStryker | 2019 Annual Review  (In order of appearance in photo, left to right) Kevin A.
","('Business_Model_Resilience', 0.16269569098949432)","('Systemic_Risk_Management', 0.11681288480758667)","('Employee_Engagement_Inclusion_And_Diversity', 0.1080845445394516)","('NON-ESG', 0.16269569098949432)","('NON-ESG', 0.11681288480758667)","('NON-ESG', 0.1080845445394516)"
Line 140,"Lobo   Chairman and   Chief Executive Officer   Glenn S.
","('Director_Removal', 0.320258766412735)","('Business_Model_Resilience', 0.21704719960689545)","('Product_Design_And_Lifecycle_Management', 0.04172275960445404)","('NON-ESG', 0.320258766412735)","('NON-ESG', 0.21704719960689545)","('NON-ESG', 0.04172275960445404)"
Line 141,"Boehnlein   Vice President,   Chief Financial Officer   Robert S.
","('Systemic_Risk_Management', 0.31874772906303406)","('Business_Model_Resilience', 0.27699950337409973)","('Director_Removal', 0.07659748941659927)","('NON-ESG', 0.31874772906303406)","('NON-ESG', 0.27699950337409973)","('NON-ESG', 0.07659748941659927)"
Line 142,"Fletcher   Vice President, Chief Legal Officer   Viju S.
","('Business_Ethics', 0.18010984361171722)","('Business_Model_Resilience', 0.15111078321933746)","('Management_Of_Legal_And_Regulatory_Framework', 0.13685184717178345)","('NON-ESG', 0.18010984361171722)","('NON-ESG', 0.15111078321933746)","('NON-ESG', 0.13685184717178345)"
Line 143,"Menon   Group President,   Global Quality and Operations   Yin C.
","('Product_Design_And_Lifecycle_Management', 0.1710713803768158)","('Management_Of_Legal_And_Regulatory_Framework', 0.1245565190911293)","('Product_Quality_And_Safety', 0.12274636328220367)","('NON-ESG', 0.1710713803768158)","('NON-ESG', 0.1245565190911293)","('NON-ESG', 0.12274636328220367)"
Line 144,"Becker   Vice President,   Communications,   Public Affairs and   Corporate Marketing   Timothy J.
","('Employee_Engagement_Inclusion_And_Diversity', 0.13021515309810638)","('Management_Of_Legal_And_Regulatory_Framework', 0.1263100504875183)","('Business_Model_Resilience', 0.11822132766246796)","('NON-ESG', 0.13021515309810638)","('NON-ESG', 0.1263100504875183)","('NON-ESG', 0.11822132766246796)"
Line 145,"Scannell   President and   Chief Operating Officer   J.
","('Business_Model_Resilience', 0.3298873007297516)","('Director_Removal', 0.14250624179840088)","('Systemic_Risk_Management', 0.05109402909874916)","('NON-ESG', 0.3298873007297516)","('NON-ESG', 0.14250624179840088)","('NON-ESG', 0.05109402909874916)"
Line 146,"Andrew Pierce   Group President, MedSurg  and NeurotechnologyDivision Presidents Businesses Xavier M.
","('Employee_Engagement_Inclusion_And_Diversity', 0.1751023381948471)","('Business_Model_Resilience', 0.15211665630340576)","('Systemic_Risk_Management', 0.07766393572092056)","('NON-ESG', 0.1751023381948471)","('NON-ESG', 0.15211665630340576)","('NON-ESG', 0.07766393572092056)"
Line 147,"C.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35686638951301575)","('Business_Ethics', 0.09611602127552032)","('Competitive_Behavior', 0.05494384095072746)","('NON-ESG', 0.35686638951301575)","('NON-ESG', 0.09611602127552032)","('NON-ESG', 0.05494384095072746)"
Line 148,"Berling   Trauma & Extremities   Dylan B.
","('Employee_Health_And_Safety', 0.1839226335287094)","('Access_And_Affordability', 0.11574383080005646)","('Supply_Chain_Management', 0.10109985619783401)","('NON-ESG', 0.1839226335287094)","('NON-ESG', 0.11574383080005646)","('NON-ESG', 0.10109985619783401)"
Line 149,"Crotty   Instruments   Brent W.
","('Management_Of_Legal_And_Regulatory_Framework', 0.11724455654621124)","('Director_Removal', 0.10801246017217636)","('Business_Ethics', 0.07399989664554596)","('NON-ESG', 0.11724455654621124)","('NON-ESG', 0.10801246017217636)","('NON-ESG', 0.07399989664554596)"
Line 150,"Ladd   Endoscopy   Eric D.
","('Access_And_Affordability', 0.21295462548732758)","('Customer_Welfare', 0.0839950442314148)","('Energy_Management', 0.07142454385757446)","('NON-ESG', 0.21295462548732758)","('NON-ESG', 0.0839950442314148)","('NON-ESG', 0.07142454385757446)"
Line 151,"Major   Spine   Mark H.
","('Employee_Health_And_Safety', 0.417173832654953)","('Employee_Engagement_Inclusion_And_Diversity', 0.09441875666379929)","('Ecological_Impacts', 0.062631756067276)","('NON-ESG', 0.417173832654953)","('NON-ESG', 0.09441875666379929)","('NON-ESG', 0.062631756067276)"
Line 152,"Paul   Neurovascular   Donald E.
","('Competitive_Behavior', 0.10861078649759293)","('Customer_Welfare', 0.10300895571708679)","('Access_And_Affordability', 0.10004840046167374)","('NON-ESG', 0.10861078649759293)","('NON-ESG', 0.10300895571708679)","('NON-ESG', 0.10004840046167374)"
Line 153,"Payerle Joint ReplacementOther Officers Dean H.
","('Labor_Practices', 0.2963615655899048)","('Management_Of_Legal_And_Regulatory_Framework', 0.2255353182554245)","('Director_Removal', 0.20039135217666626)","('NON-ESG', 0.2963615655899048)","('NON-ESG', 0.2255353182554245)","('NON-ESG', 0.20039135217666626)"
Line 154,"Bergy    Vice President,  Corporate Secretary William E.
","('Director_Removal', 0.4761357307434082)","('Management_Of_Legal_And_Regulatory_Framework', 0.09083042293787003)","('Business_Ethics', 0.05523144453763962)","('NON-ESG', 0.4761357307434082)","('NON-ESG', 0.09083042293787003)","('NON-ESG', 0.05523144453763962)"
Line 155,"Berry Jr.    Vice President,  Corporate Controller Jeanne M.
","('Director_Removal', 0.3543386161327362)","('Employee_Engagement_Inclusion_And_Diversity', 0.1010952964425087)","('Business_Model_Resilience', 0.08682408183813095)","('NON-ESG', 0.3543386161327362)","('NON-ESG', 0.1010952964425087)","('NON-ESG', 0.08682408183813095)"
Line 156,"Blondia   Vice President,   Finance and Treasurer Irene B.
","('Director_Removal', 0.4699201285839081)","('Management_Of_Legal_And_Regulatory_Framework', 0.11706089228391647)","('Employee_Engagement_Inclusion_And_Diversity', 0.07429561764001846)","('NON-ESG', 0.4699201285839081)","('NON-ESG', 0.11706089228391647)","('NON-ESG', 0.07429561764001846)"
Line 157,"Corbe   Vice President,  Internal Audit William J.
","('Business_Ethics', 0.4993498921394348)","('Systemic_Risk_Management', 0.10889459401369095)","('Management_Of_Legal_And_Regulatory_Framework', 0.09855204075574875)","('NON-ESG', 0.4993498921394348)","('NON-ESG', 0.10889459401369095)","('NON-ESG', 0.09855204075574875)"
Line 158,"Cymbaluk    Vice President, Corporate  Regulatory Affairs and  Quality Assurance David G.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8760759830474854)","('Business_Ethics', 0.024136174470186234)","('Systemic_Risk_Management', 0.012873000465333462)","(['Corporate Governance'], 0.8760759830474854)","('NON-ESG', 0.024136174470186234)","('NON-ESG', 0.012873000465333462)"
Line 159,"Furgason    Vice President, Tax Jody K.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7266483306884766)","('Competitive_Behavior', 0.058186162263154984)","('Business_Ethics', 0.03978092968463898)","(['Corporate Governance'], 0.7266483306884766)","('NON-ESG', 0.058186162263154984)","('NON-ESG', 0.03978092968463898)"
Line 160,"Powell Vice President,  Global RAQA Bronwen R.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28833141922950745)","('Systemic_Risk_Management', 0.1087321937084198)","('Business_Model_Resilience', 0.0990520790219307)","('NON-ESG', 0.28833141922950745)","('NON-ESG', 0.1087321937084198)","('NON-ESG', 0.0990520790219307)"
Line 161,"Taylor    Vice President,  Compliance and Risk  ManagementRegions Maurice Ben-Mayor   South Pacific   Silvia L.
","('Systemic_Risk_Management', 0.4783618450164795)","('Management_Of_Legal_And_Regulatory_Framework', 0.14839376509189606)","('Business_Ethics', 0.08283684402704239)","('NON-ESG', 0.4783618450164795)","('NON-ESG', 0.14839376509189606)","('NON-ESG', 0.08283684402704239)"
Line 162,"F.
","('GHG_Emissions', 0.15389062464237213)","('Management_Of_Legal_And_Regulatory_Framework', 0.11919295787811279)","('Competitive_Behavior', 0.11879564821720123)","('NON-ESG', 0.15389062464237213)","('NON-ESG', 0.11919295787811279)","('NON-ESG', 0.11879564821720123)"
Line 163,"Braga   Latin America   Dragana Bunjevac   Eastern Europe,   Middle East, Africa   Scott A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2040075957775116)","('Business_Model_Resilience', 0.12397980690002441)","('Competitive_Behavior', 0.08093941956758499)","('NON-ESG', 0.2040075957775116)","('NON-ESG', 0.12397980690002441)","('NON-ESG', 0.08093941956758499)"
Line 164,"MacNair   Canada Graham A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5053607225418091)","('Business_Ethics', 0.11768391728401184)","('Director_Removal', 0.06439555436372757)","(['Corporate Governance'], 0.5053607225418091)","('NON-ESG', 0.11768391728401184)","('NON-ESG', 0.06439555436372757)"
Line 165,"McLean   Asia Pacific  Leadership   team Spencer S.
","('Business_Model_Resilience', 0.36440202593803406)","('Employee_Engagement_Inclusion_And_Diversity', 0.25535452365875244)","('Director_Removal', 0.05759222060441971)","('NON-ESG', 0.36440202593803406)","('NON-ESG', 0.25535452365875244)","('NON-ESG', 0.05759222060441971)"
Line 166,"Stiles   Group President,   Orthopaedics and Spine   M.
","('Access_And_Affordability', 0.37344038486480713)","('Employee_Engagement_Inclusion_And_Diversity', 0.20440255105495453)","('Employee_Health_And_Safety', 0.08010207861661911)","('NON-ESG', 0.37344038486480713)","('NON-ESG', 0.20440255105495453)","('NON-ESG', 0.08010207861661911)"
Line 167,"Kathryn (Katy) Fink   Vice President,   Chief Human Resources Officer   Katherine A.
","('Employee_Engagement_Inclusion_And_Diversity', 0.28971001505851746)","('Business_Model_Resilience', 0.24553826451301575)","('Supply_Chain_Management', 0.04773547127842903)","('NON-ESG', 0.28971001505851746)","('NON-ESG', 0.24553826451301575)","('NON-ESG', 0.04773547127842903)"
Line 168,"Owen   Vice President,   Strategy and Investor RelationsBradford L.
","('Business_Model_Resilience', 0.5919744968414307)","('Employee_Engagement_Inclusion_And_Diversity', 0.05177906155586243)","('Director_Removal', 0.037786420434713364)","(['Codes of Business Conduct'], 0.5919744968414307)","('NON-ESG', 0.05177906155586243)","('NON-ESG', 0.037786420434713364)"
Line 169,"Saar   Medical   Brian J.
","('Access_And_Affordability', 0.1315869837999344)","('Supply_Chain_Management', 0.10030940175056458)","('Systemic_Risk_Management', 0.0790633037686348)","('NON-ESG', 0.1315869837999344)","('NON-ESG', 0.10030940175056458)","('NON-ESG', 0.0790633037686348)"
Line 170,"White   Sustainability Solutions Hiroyuki Saeki   Japan   Stuart A.
","('Product_Design_And_Lifecycle_Management', 0.6193355321884155)","('Supply_Chain_Management', 0.07957692444324493)","('Business_Model_Resilience', 0.0617075115442276)","(['Product Stewardship'], 0.6193355321884155)","('NON-ESG', 0.07957692444324493)","('NON-ESG', 0.0617075115442276)"
Line 171,"J.
","('Waste_And_Hazardous_Materials_Management', 0.09462015330791473)","('Product_Design_And_Lifecycle_Management', 0.07801306992769241)","('Employee_Engagement_Inclusion_And_Diversity', 0.06643947958946228)","('NON-ESG', 0.09462015330791473)","('NON-ESG', 0.07801306992769241)","('NON-ESG', 0.06643947958946228)"
Line 172,"Silk   Europe, Middle East,  Africa, Latin America,  CanadaStryker | 2019 Annual Review  (In order of appearance in photo, left to right) Louise L.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21264156699180603)","('Business_Model_Resilience', 0.14212116599082947)","('Competitive_Behavior', 0.08268757164478302)","('NON-ESG', 0.21264156699180603)","('NON-ESG', 0.14212116599082947)","('NON-ESG', 0.08268757164478302)"
Line 173,"Francesconi ‡ §  Rajeev Suri  **   Ronda E.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6541216373443604)","('Director_Removal', 0.04398344084620476)","('Labor_Practices', 0.037207599729299545)","(['Corporate Governance'], 0.6541216373443604)","('NON-ESG', 0.04398344084620476)","('NON-ESG', 0.037207599729299545)"
Line 174,"Stryker §  Mary K.
","('Employee_Engagement_Inclusion_And_Diversity', 0.17221882939338684)","('Business_Ethics', 0.13582052290439606)","('Labor_Practices', 0.09047006815671921)","('NON-ESG', 0.17221882939338684)","('NON-ESG', 0.13582052290439606)","('NON-ESG', 0.09047006815671921)"
Line 175,"Brainerd **  Chairman Emeritus John W.
","('Director_Removal', 0.4223179519176483)","('Business_Model_Resilience', 0.08024615049362183)","('Employee_Engagement_Inclusion_And_Diversity', 0.06148308515548706)","('NON-ESG', 0.4223179519176483)","('NON-ESG', 0.08024615049362183)","('NON-ESG', 0.06148308515548706)"
Line 176,"Brown   Former Chairman, President and   Chief Executive Officer  Director Emeritus Howard E.
","('Director_Removal', 0.3096928596496582)","('Business_Model_Resilience', 0.1277923882007599)","('Management_Of_Legal_And_Regulatory_Framework', 0.0642085075378418)","('NON-ESG', 0.3096928596496582)","('NON-ESG', 0.1277923882007599)","('NON-ESG', 0.0642085075378418)"
Line 177,"Cox, Jr.Board of   DirectorsWith appreciation Louise L.
","('Director_Removal', 0.5784555077552795)","('Management_Of_Legal_And_Regulatory_Framework', 0.05210502818226814)","('Employee_Engagement_Inclusion_And_Diversity', 0.04883984848856926)","(['Anti-Crime Policy & Measures'], 0.5784555077552795)","('NON-ESG', 0.05210502818226814)","('NON-ESG', 0.04883984848856926)"
Line 178,"Francesconi We want to express our gratitude and  appreciation to Louise Francesconi who  has served as a director on our board  since 2006.
","('Director_Removal', 0.5734850764274597)","('Business_Model_Resilience', 0.05448588356375694)","('Management_Of_Legal_And_Regulatory_Framework', 0.04539956524968147)","(['Anti-Crime Policy & Measures'], 0.5734850764274597)","('NON-ESG', 0.05448588356375694)","('NON-ESG', 0.04539956524968147)"
Line 179,"Louise has made strong  contributions to our strategy and growth  during her 14 years on our board and  successfully hired many new board  members as chair of the governance  and nominating committee since 2007.
","('Director_Removal', 0.6616213917732239)","('Management_Of_Legal_And_Regulatory_Framework', 0.06147332862019539)","('Business_Model_Resilience', 0.044942691922187805)","(['Anti-Crime Policy & Measures'], 0.6616213917732239)","('NON-ESG', 0.06147332862019539)","('NON-ESG', 0.044942691922187805)"
Line 180,"We sincerely thank Louise for her  dedication and service.
","('Human_Rights_And_Community_Relations', 0.21672210097312927)","('Management_Of_Legal_And_Regulatory_Framework', 0.08107907325029373)","('Employee_Health_And_Safety', 0.07246372848749161)","('NON-ESG', 0.21672210097312927)","('NON-ESG', 0.08107907325029373)","('NON-ESG', 0.07246372848749161)"
Line 181,"* Chairman of the Board  † Lead Independent Director ** Audit Committee  ‡ Compensation Committee  §  Governance and Nominating CommitteeAndrew K.
","('Director_Removal', 0.7478511333465576)","('Management_Of_Legal_And_Regulatory_Framework', 0.05895569920539856)","('Business_Ethics', 0.02254003845155239)","(['Anti-Crime Policy & Measures'], 0.7478511333465576)","('NON-ESG', 0.05895569920539856)","('NON-ESG', 0.02254003845155239)"
Line 182,"Silvernail  **  Allan C.
","('Business_Ethics', 0.124321848154068)","('Competitive_Behavior', 0.11588671803474426)","('Supply_Chain_Management', 0.06787128746509552)","('NON-ESG', 0.124321848154068)","('NON-ESG', 0.11588671803474426)","('NON-ESG', 0.06787128746509552)"
Line 183,"Golston † **   Srikant M.
","('Competitive_Behavior', 0.1346724033355713)","('Management_Of_Legal_And_Regulatory_Framework', 0.1251278668642044)","('Business_Ethics', 0.11758667230606079)","('NON-ESG', 0.1346724033355713)","('NON-ESG', 0.1251278668642044)","('NON-ESG', 0.11758667230606079)"
Line 184,"Datar, Ph.D. ‡ §  Roch Doliveux, D.V.M.  ‡ §   Sherilyn S.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5483484268188477)","('Business_Ethics', 0.09190244227647781)","('Competitive_Behavior', 0.07646773010492325)","(['Corporate Governance'], 0.5483484268188477)","('NON-ESG', 0.09190244227647781)","('NON-ESG', 0.07646773010492325)"
Line 185,"McCoy ‡ §  Kevin A.
","('Director_Removal', 0.19759462773799896)","('Employee_Engagement_Inclusion_And_Diversity', 0.13631898164749146)","('Business_Ethics', 0.09037454426288605)","('NON-ESG', 0.19759462773799896)","('NON-ESG', 0.13631898164749146)","('NON-ESG', 0.09037454426288605)"
Line 186,"Lobo *Stryker | 2019 Annual Review  21Refer to our 2019 Annual Report on Form 10-K, available at stryker.com, for additional information regarding our non-GAAP financial measures.Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure Net earnings ($ millions) Net earnings per diluted share 2014 2015 2016 2017 2018 2019 2014 2015 2016 2017 2018 Reported $515 $1,439 $1,647 $1,020 $3,553 $2,083 $1.34 $3.78 $4.35 $2.68 $9.34 $5.Acquisition and integration-related charges Inventory stepped-up to fair value 15 4 23 20 9 51 0.04 0.01 0.06 0.05 0.02 0.Other acquisition and integration-related 50 20 77 31 90 160 0.13 0.05 0.20 0.09 0.24 0.Amortization of purchased intangible assets 133 147 221 250 338 375 0.35 0.39 0.59 0.67 0.89 0.Restructuring-related and other charges 78 97 98 155 179 180 0.20 0.26 0.26 0.41 0.47 0.Medical device regulations – – – – 10 48 – – – – 0.03 0.Recall-related matters 628 210 127 131 18 154 1.65 0.55 0.34 0.34 0.05 0.Regulatory and legal matters – (46) (7) 25 141 (33) – (0.12) (0.02) 0.06 0.37 (0.09) Tax matters 391 78 8 833 (1,559) 121 1.02 0.20 0.02 2.19 (4.10) 0.Adjusted $1,810 $1,949 $2,194 $2,465 $2,779 $3,139 $4.73 $5.12 $5.80 $6.49 $7.31 $8.Effective Tax Rate — Reported 55.6% 17.1% 14.3% 50.6% (50.8)% 18.7% Effective Tax Rate — Adjusted 22.3% 17.3% 17.3% 15.6% 16.7% 15.8% Weighted average diluted shares outstanding 382.8 380.9 378.5 380.1 380.3 379.References from page 1.
","('Systemic_Risk_Management', 0.4384554624557495)","('Management_Of_Legal_And_Regulatory_Framework', 0.2268599271774292)","('Business_Model_Resilience', 0.06854396313428879)","('NON-ESG', 0.4384554624557495)","('NON-ESG', 0.2268599271774292)","('NON-ESG', 0.06854396313428879)"
Line 187,"Lobo *Stryker | 2019 Annual Review  21Refer to our 2019 Annual Report on Form 10-K, available at stryker.com, for additional information regarding our non-GAAP financial measures.Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure Net earnings ($ millions) Net earnings per diluted share 2014 2015 2016 2017 2018 2019 2014 2015 2016 2017 2018 Reported $515 $1,439 $1,647 $1,020 $3,553 $2,083 $1.34 $3.78 $4.35 $2.68 $9.34 $5.Acquisition and integration-related charges Inventory stepped-up to fair value 15 4 23 20 9 51 0.04 0.01 0.06 0.05 0.02 0.Other acquisition and integration-related 50 20 77 31 90 160 0.13 0.05 0.20 0.09 0.24 0.Amortization of purchased intangible assets 133 147 221 250 338 375 0.35 0.39 0.59 0.67 0.89 0.Restructuring-related and other charges 78 97 98 155 179 180 0.20 0.26 0.26 0.41 0.47 0.Medical device regulations – – – – 10 48 – – – – 0.03 0.Recall-related matters 628 210 127 131 18 154 1.65 0.55 0.34 0.34 0.05 0.Regulatory and legal matters – (46) (7) 25 141 (33) – (0.12) (0.02) 0.06 0.37 (0.09) Tax matters 391 78 8 833 (1,559) 121 1.02 0.20 0.02 2.19 (4.10) 0.Adjusted $1,810 $1,949 $2,194 $2,465 $2,779 $3,139 $4.73 $5.12 $5.80 $6.49 $7.31 $8.Effective Tax Rate — Reported 55.6% 17.1% 14.3% 50.6% (50.8)% 18.7% Effective Tax Rate — Adjusted 22.3% 17.3% 17.3% 15.6% 16.7% 15.8% Weighted average diluted shares outstanding 382.8 380.9 378.5 380.1 380.3 379.References from page 1.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8994943499565125)","('Business_Ethics', 0.026511888951063156)","('Competitive_Behavior', 0.014342029578983784)","(['Corporate Governance'], 0.8994943499565125)","('NON-ESG', 0.026511888951063156)","('NON-ESG', 0.014342029578983784)"
Line 188,"Lobo *Stryker | 2019 Annual Review  21Refer to our 2019 Annual Report on Form 10-K, available at stryker.com, for additional information regarding our non-GAAP financial measures.Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure Net earnings ($ millions) Net earnings per diluted share 2014 2015 2016 2017 2018 2019 2014 2015 2016 2017 2018 Reported $515 $1,439 $1,647 $1,020 $3,553 $2,083 $1.34 $3.78 $4.35 $2.68 $9.34 $5.Acquisition and integration-related charges Inventory stepped-up to fair value 15 4 23 20 9 51 0.04 0.01 0.06 0.05 0.02 0.Other acquisition and integration-related 50 20 77 31 90 160 0.13 0.05 0.20 0.09 0.24 0.Amortization of purchased intangible assets 133 147 221 250 338 375 0.35 0.39 0.59 0.67 0.89 0.Restructuring-related and other charges 78 97 98 155 179 180 0.20 0.26 0.26 0.41 0.47 0.Medical device regulations – – – – 10 48 – – – – 0.03 0.Recall-related matters 628 210 127 131 18 154 1.65 0.55 0.34 0.34 0.05 0.Regulatory and legal matters – (46) (7) 25 141 (33) – (0.12) (0.02) 0.06 0.37 (0.09) Tax matters 391 78 8 833 (1,559) 121 1.02 0.20 0.02 2.19 (4.10) 0.Adjusted $1,810 $1,949 $2,194 $2,465 $2,779 $3,139 $4.73 $5.12 $5.80 $6.49 $7.31 $8.Effective Tax Rate — Reported 55.6% 17.1% 14.3% 50.6% (50.8)% 18.7% Effective Tax Rate — Adjusted 22.3% 17.3% 17.3% 15.6% 16.7% 15.8% Weighted average diluted shares outstanding 382.8 380.9 378.5 380.1 380.3 379.References from page 1.
","('Management_Of_Legal_And_Regulatory_Framework', 0.95209801197052)","('Business_Ethics', 0.004456094931811094)","('Director_Removal', 0.004374255426228046)","(['Corporate Governance'], 0.95209801197052)","('NON-ESG', 0.004456094931811094)","('NON-ESG', 0.004374255426228046)"
Line 189,"Illgen R, Bukowski B, Abiola R, Anderson P, Chughtai M, Khlopas A, Mont M.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2642401456832886)","('Human_Rights_And_Community_Relations', 0.11853060871362686)","('GHG_Emissions', 0.08529210090637207)","('NON-ESG', 0.2642401456832886)","('NON-ESG', 0.11853060871362686)","('NON-ESG', 0.08529210090637207)"
Line 190,"Robotic-assisted total hip  arthroplasty: Outcomes at minimum two year follow up.
","('Access_And_Affordability', 0.3298952281475067)","('Employee_Health_And_Safety', 0.2833068370819092)","('Employee_Engagement_Inclusion_And_Diversity', 0.07464645057916641)","('NON-ESG', 0.3298952281475067)","('NON-ESG', 0.2833068370819092)","('NON-ESG', 0.07464645057916641)"
Line 191,"Surgical Technology International.
","('Product_Design_And_Lifecycle_Management', 0.44112855195999146)","('Product_Quality_And_Safety', 0.08270283788442612)","('Data_Security', 0.04202907159924507)","('NON-ESG', 0.44112855195999146)","('NON-ESG', 0.08270283788442612)","('NON-ESG', 0.04202907159924507)"
Line 192,"2017 July 25; 30:365-372.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34440121054649353)","('Systemic_Risk_Management', 0.11355474591255188)","('Business_Ethics', 0.060636766254901886)","('NON-ESG', 0.34440121054649353)","('NON-ESG', 0.11355474591255188)","('NON-ESG', 0.060636766254901886)"
Line 193,"2.
","('Competitive_Behavior', 0.15795664489269257)","('Customer_Welfare', 0.10852150619029999)","('Energy_Management', 0.08616163581609726)","('NON-ESG', 0.15795664489269257)","('NON-ESG', 0.10852150619029999)","('NON-ESG', 0.08616163581609726)"
Line 194,"Kayani B, Konan S, Tahmassebi J, Pietrzak JRT, Haddad FS.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22156170010566711)","('Competitive_Behavior', 0.09798216074705124)","('Business_Ethics', 0.09484673291444778)","('NON-ESG', 0.22156170010566711)","('NON-ESG', 0.09798216074705124)","('NON-ESG', 0.09484673291444778)"
Line 195,"Robotic arm assisted total knee arthroplasty  is associated with improved early functional recovery and reduced time to hospital discharge compared  with conventional jig-based total knee arthroplasty: a prospective cohort study.
","('Employee_Health_And_Safety', 0.8712985515594482)","('Access_And_Affordability', 0.01883338764309883)","('Employee_Engagement_Inclusion_And_Diversity', 0.01478518731892109)","(['Operational Eco-Efficiency'], 0.8712985515594482)","('NON-ESG', 0.01883338764309883)","('NON-ESG', 0.01478518731892109)"
Line 196,"The Bone and Joint Journal.
","('Employee_Health_And_Safety', 0.2602117359638214)","('Employee_Engagement_Inclusion_And_Diversity', 0.1321803629398346)","('Ecological_Impacts', 0.09398406744003296)","('NON-ESG', 0.2602117359638214)","('NON-ESG', 0.1321803629398346)","('NON-ESG', 0.09398406744003296)"
Line 197,"2018;100-B:930-7.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39319267868995667)","('Ecological_Impacts', 0.060077980160713196)","('Competitive_Behavior', 0.05418018996715546)","('NON-ESG', 0.39319267868995667)","('NON-ESG', 0.060077980160713196)","('NON-ESG', 0.05418018996715546)"
Line 198,"3.
","('Competitive_Behavior', 0.1465800553560257)","('Customer_Welfare', 0.10041514039039612)","('Product_Design_And_Lifecycle_Management', 0.07025990635156631)","('NON-ESG', 0.1465800553560257)","('NON-ESG', 0.10041514039039612)","('NON-ESG', 0.07025990635156631)"
Line 199,"Kleeblad LJ, Borus T, Coon T, Dounchis J, Nguyen J, Pearle A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.19809821248054504)","('Competitive_Behavior', 0.15961194038391113)","('Business_Ethics', 0.10146038979291916)","('NON-ESG', 0.19809821248054504)","('NON-ESG', 0.15961194038391113)","('NON-ESG', 0.10146038979291916)"
Line 200,"Midterm survivorship and patient satisfaction of  robotic-arm assisted medial unicompartmental knee arthroplasty: a multicenter study.
","('Employee_Health_And_Safety', 0.40231838822364807)","('Access_And_Affordability', 0.24449265003204346)","('Employee_Engagement_Inclusion_And_Diversity', 0.056786831468343735)","('NON-ESG', 0.40231838822364807)","('NON-ESG', 0.24449265003204346)","('NON-ESG', 0.056786831468343735)"
Line 201,"The Journal of Arthroplasty.
","('Ecological_Impacts', 0.4729904234409332)","('Employee_Engagement_Inclusion_And_Diversity', 0.09702891856431961)","('Access_And_Affordability', 0.05370325595140457)","('NON-ESG', 0.4729904234409332)","('NON-ESG', 0.09702891856431961)","('NON-ESG', 0.05370325595140457)"
Line 202,"2018:1-8.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20597560703754425)","('Data_Security', 0.07849647849798203)","('Systemic_Risk_Management', 0.0775286853313446)","('NON-ESG', 0.20597560703754425)","('NON-ESG', 0.07849647849798203)","('NON-ESG', 0.0775286853313446)"
Line 203,"4.
","('Competitive_Behavior', 0.1400022953748703)","('GHG_Emissions', 0.0895392969250679)","('Customer_Welfare', 0.0845675989985466)","('NON-ESG', 0.1400022953748703)","('NON-ESG', 0.0895392969250679)","('NON-ESG', 0.0845675989985466)"
Line 204,"Anthony I, Bell SW, Blyth M, Jones B, et al.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23428800702095032)","('Competitive_Behavior', 0.12986443936824799)","('Ecological_Impacts', 0.11463771760463715)","('NON-ESG', 0.23428800702095032)","('NON-ESG', 0.12986443936824799)","('NON-ESG', 0.11463771760463715)"
Line 205,"Improved accuracy of component positioning with robotic-assisted  unicompartmental knee arthroplasty.
","('Employee_Health_And_Safety', 0.6216921806335449)","('Employee_Engagement_Inclusion_And_Diversity', 0.060382477939128876)","('Access_And_Affordability', 0.04765256121754646)","(['Operational Eco-Efficiency'], 0.6216921806335449)","('NON-ESG', 0.060382477939128876)","('NON-ESG', 0.04765256121754646)"
Line 206,"J Bone Joint Surg Am. 2016;98-A(8):627-35.
","('Management_Of_Legal_And_Regulatory_Framework', 0.414972186088562)","('Ecological_Impacts', 0.06424424797296524)","('Competitive_Behavior', 0.06042671576142311)","('NON-ESG', 0.414972186088562)","('NON-ESG', 0.06424424797296524)","('NON-ESG', 0.06042671576142311)"
Line 207,"5.
","('Competitive_Behavior', 0.15210691094398499)","('Energy_Management', 0.09276141971349716)","('Customer_Welfare', 0.08200553804636002)","('NON-ESG', 0.15210691094398499)","('NON-ESG', 0.09276141971349716)","('NON-ESG', 0.08200553804636002)"
Line 208,"Mahoney O, Kinsey T, Mont M, Hozack W, Orozco F, Chen A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23208846151828766)","('Competitive_Behavior', 0.10677576065063477)","('Human_Rights_And_Community_Relations', 0.09790367633104324)","('NON-ESG', 0.23208846151828766)","('NON-ESG', 0.10677576065063477)","('NON-ESG', 0.09790367633104324)"
Line 209,"Can computer generated 3D bone models improve  the accuracy of total knee component placement compared to manual instrumentation: a prospective multi- center evaluation?
","('Employee_Health_And_Safety', 0.7365515232086182)","('Employee_Engagement_Inclusion_And_Diversity', 0.049822814762592316)","('Ecological_Impacts', 0.022597581148147583)","(['Operational Eco-Efficiency'], 0.7365515232086182)","('NON-ESG', 0.049822814762592316)","('NON-ESG', 0.022597581148147583)"
Line 210,"International Society for Technology in Arthroplasty 32nd Annual Congress.
","('Ecological_Impacts', 0.3125518560409546)","('Access_And_Affordability', 0.10251380503177643)","('Management_Of_Legal_And_Regulatory_Framework', 0.06692502647638321)","('NON-ESG', 0.3125518560409546)","('NON-ESG', 0.10251380503177643)","('NON-ESG', 0.06692502647638321)"
Line 211,"Toronto, Canada.
","('Management_Of_Legal_And_Regulatory_Framework', 0.22145068645477295)","('Competitive_Behavior', 0.11108918488025665)","('Energy_Management', 0.07419843971729279)","('NON-ESG', 0.22145068645477295)","('NON-ESG', 0.11108918488025665)","('NON-ESG', 0.07419843971729279)"
Line 212,"October 2-5, 2019.6. Suarez-Ahedo C; Gui C; Martin T; Chandrasekaran S; Domb B.
","('Management_Of_Legal_And_Regulatory_Framework', 0.562760055065155)","('Director_Removal', 0.064313143491745)","('Ecological_Impacts', 0.038225799798965454)","(['Corporate Governance'], 0.562760055065155)","('NON-ESG', 0.064313143491745)","('NON-ESG', 0.038225799798965454)"
Line 213,"Robotic arm assisted total hip arthroplasty results  in smaller acetabular cup size in relation to the femoral head size: A Matched-Pair Controlled Study.
","('Employee_Health_And_Safety', 0.31177687644958496)","('Employee_Engagement_Inclusion_And_Diversity', 0.12043099850416183)","('Ecological_Impacts', 0.11847750842571259)","('NON-ESG', 0.31177687644958496)","('NON-ESG', 0.12043099850416183)","('NON-ESG', 0.11847750842571259)"
Line 214,"Hip Int.
","('Employee_Engagement_Inclusion_And_Diversity', 0.08960714191198349)","('Ecological_Impacts', 0.08788814395666122)","('Business_Model_Resilience', 0.06387661397457123)","('NON-ESG', 0.08960714191198349)","('NON-ESG', 0.08788814395666122)","('NON-ESG', 0.06387661397457123)"
Line 215,"2017; 27  (2): 147-152.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20814594626426697)","('Systemic_Risk_Management', 0.11752722412347794)","('Competitive_Behavior', 0.07745062559843063)","('NON-ESG', 0.20814594626426697)","('NON-ESG', 0.11752722412347794)","('NON-ESG', 0.07745062559843063)"
Line 216,"7.
","('Competitive_Behavior', 0.14777089655399323)","('Management_Of_Legal_And_Regulatory_Framework', 0.09013563394546509)","('Energy_Management', 0.08286081999540329)","('NON-ESG', 0.14777089655399323)","('NON-ESG', 0.09013563394546509)","('NON-ESG', 0.08286081999540329)"
Line 217,"Haddad FS, et al.
","('Ecological_Impacts', 0.15619905292987823)","('Management_Of_Legal_And_Regulatory_Framework', 0.1509023755788803)","('Competitive_Behavior', 0.14248615503311157)","('NON-ESG', 0.15619905292987823)","('NON-ESG', 0.1509023755788803)","('NON-ESG', 0.14248615503311157)"
Line 218,"Iatrogenic Bone and Soft Tissue Trauma in Robotic-Arm Assisted Total Knee Arthroplasty  Compared With Conventional Jig-Based Total Knee Arthroplasty: A Prospective Cohort Study and Validation of a New  Classification System.
","('Employee_Health_And_Safety', 0.8403730392456055)","('Critical_Incident_Risk_Management', 0.027204278856515884)","('Waste_And_Hazardous_Materials_Management', 0.021929331123828888)","(['Operational Eco-Efficiency'], 0.8403730392456055)","('NON-ESG', 0.027204278856515884)","('NON-ESG', 0.021929331123828888)"
Line 219,"J Arthroplasty.
","('Ecological_Impacts', 0.7212021946907043)","('GHG_Emissions', 0.036953844130039215)","('Employee_Engagement_Inclusion_And_Diversity', 0.0269016083329916)","(['Natural Capital'], 0.7212021946907043)","('NON-ESG', 0.036953844130039215)","('NON-ESG', 0.0269016083329916)"
Line 220,"2018 Aug;33(8):2496-2501.
","('Management_Of_Legal_And_Regulatory_Framework', 0.30864614248275757)","('Systemic_Risk_Management', 0.09998984634876251)","('Competitive_Behavior', 0.09849078208208084)","('NON-ESG', 0.30864614248275757)","('NON-ESG', 0.09998984634876251)","('NON-ESG', 0.09849078208208084)"
Line 221,"Epub 2018 Mar 27.
","('Business_Model_Resilience', 0.14781440794467926)","('Management_Of_Legal_And_Regulatory_Framework', 0.12969297170639038)","('Product_Design_And_Lifecycle_Management', 0.08804185688495636)","('NON-ESG', 0.14781440794467926)","('NON-ESG', 0.12969297170639038)","('NON-ESG', 0.08804185688495636)"
Line 222,"8.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16766208410263062)","('Competitive_Behavior', 0.16316792368888855)","('GHG_Emissions', 0.06603232771158218)","('NON-ESG', 0.16766208410263062)","('NON-ESG', 0.16316792368888855)","('NON-ESG', 0.06603232771158218)"
Line 223,"Hozack WJ.
","('Competitive_Behavior', 0.47823819518089294)","('Business_Ethics', 0.12517058849334717)","('Management_Of_Legal_And_Regulatory_Framework', 0.062107354402542114)","('NON-ESG', 0.47823819518089294)","('NON-ESG', 0.12517058849334717)","('NON-ESG', 0.062107354402542114)"
Line 224,"Multicentre analysis of outcomes after robotic-arm assisted total knee arthroplasty.
","('Ecological_Impacts', 0.2644960284233093)","('Access_And_Affordability', 0.15185406804084778)","('Employee_Health_And_Safety', 0.13378511369228363)","('NON-ESG', 0.2644960284233093)","('NON-ESG', 0.15185406804084778)","('NON-ESG', 0.13378511369228363)"
Line 225,"Orthop Proc.
","('Ecological_Impacts', 0.23164713382720947)","('Business_Ethics', 0.06652994453907013)","('Employee_Engagement_Inclusion_And_Diversity', 0.06538459658622742)","('NON-ESG', 0.23164713382720947)","('NON-ESG', 0.06652994453907013)","('NON-ESG', 0.06538459658622742)"
Line 226,"2018;100-B(SUPP_12):38.
","('Management_Of_Legal_And_Regulatory_Framework', 0.42415279150009155)","('Competitive_Behavior', 0.10427401959896088)","('Ecological_Impacts', 0.07350950688123703)","('NON-ESG', 0.42415279150009155)","('NON-ESG', 0.10427401959896088)","('NON-ESG', 0.07350950688123703)"
Line 227,"9.
","('Competitive_Behavior', 0.18031731247901917)","('Management_Of_Legal_And_Regulatory_Framework', 0.11814294010400772)","('GHG_Emissions', 0.07382970303297043)","('NON-ESG', 0.18031731247901917)","('NON-ESG', 0.11814294010400772)","('NON-ESG', 0.07382970303297043)"
Line 228,"Banks, Scott A, PhD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23377135396003723)","('Ecological_Impacts', 0.18479084968566895)","('Competitive_Behavior', 0.07608561217784882)","('NON-ESG', 0.23377135396003723)","('NON-ESG', 0.18479084968566895)","('NON-ESG', 0.07608561217784882)"
Line 229,"Haptic Robotics Enable a Systems Approach to Design of a Minimally Invasive Modular Knee  Arthroplasty.
","('Product_Design_And_Lifecycle_Management', 0.18474794924259186)","('Access_And_Affordability', 0.10157202929258347)","('Employee_Health_And_Safety', 0.09966855496168137)","('NON-ESG', 0.18474794924259186)","('NON-ESG', 0.10157202929258347)","('NON-ESG', 0.09966855496168137)"
Line 230,"Am J Orthop.
","('Ecological_Impacts', 0.25247013568878174)","('Employee_Engagement_Inclusion_And_Diversity', 0.13835778832435608)","('Business_Ethics', 0.06980682164430618)","('NON-ESG', 0.25247013568878174)","('NON-ESG', 0.13835778832435608)","('NON-ESG', 0.06980682164430618)"
Line 231,"2009;38(2 suppl):23-27.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3028295636177063)","('Competitive_Behavior', 0.15490928292274475)","('Ecological_Impacts', 0.08488666266202927)","('NON-ESG', 0.3028295636177063)","('NON-ESG', 0.15490928292274475)","('NON-ESG', 0.08488666266202927)"
Line 232,"February 2009.
","('Management_Of_Legal_And_Regulatory_Framework', 0.0809558779001236)","('Business_Ethics', 0.07703336328268051)","('Director_Removal', 0.0740651786327362)","('NON-ESG', 0.0809558779001236)","('NON-ESG', 0.07703336328268051)","('NON-ESG', 0.0740651786327362)"
Line 233,"10.
","('Competitive_Behavior', 0.1053069457411766)","('Management_Of_Legal_And_Regulatory_Framework', 0.09258180856704712)","('GHG_Emissions', 0.06819628924131393)","('NON-ESG', 0.1053069457411766)","('NON-ESG', 0.09258180856704712)","('NON-ESG', 0.06819628924131393)"
Line 234,"Hampp E, Chang TC, Pearle A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21956612169742584)","('Competitive_Behavior', 0.15403908491134644)","('Business_Ethics', 0.12363656610250473)","('NON-ESG', 0.21956612169742584)","('NON-ESG', 0.15403908491134644)","('NON-ESG', 0.12363656610250473)"
Line 235,"Robotic partial knee arthroplasty demonstrated greater bone preservation  compared to robotic total knee arthroplasty.
","('Ecological_Impacts', 0.30383169651031494)","('Employee_Health_And_Safety', 0.24004770815372467)","('Waste_And_Hazardous_Materials_Management', 0.07273721694946289)","('NON-ESG', 0.30383169651031494)","('NON-ESG', 0.24004770815372467)","('NON-ESG', 0.07273721694946289)"
Line 236,"Annual Orthopaedic Research Society.
","('Access_And_Affordability', 0.7860216498374939)","('Employee_Health_And_Safety', 0.030018076300621033)","('Employee_Engagement_Inclusion_And_Diversity', 0.02751792035996914)","(['Health Outcome Contribution'], 0.7860216498374939)","('NON-ESG', 0.030018076300621033)","('NON-ESG', 0.02751792035996914)"
Line 237,"Austin, TX.
","('Business_Model_Resilience', 0.15642638504505157)","('Competitive_Behavior', 0.0817839577794075)","('Management_Of_Legal_And_Regulatory_Framework', 0.07985034584999084)","('NON-ESG', 0.15642638504505157)","('NON-ESG', 0.0817839577794075)","('NON-ESG', 0.07985034584999084)"
Line 238,"2-5 Feb 2019.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1338583528995514)","('Business_Model_Resilience', 0.13183514773845673)","('Director_Removal', 0.07188793271780014)","('NON-ESG', 0.1338583528995514)","('NON-ESG', 0.13183514773845673)","('NON-ESG', 0.07188793271780014)"
Line 239,"11.
","('Competitive_Behavior', 0.09102239459753036)","('Management_Of_Legal_And_Regulatory_Framework', 0.08299843966960907)","('Energy_Management', 0.065489262342453)","('NON-ESG', 0.09102239459753036)","('NON-ESG', 0.08299843966960907)","('NON-ESG', 0.065489262342453)"
Line 240,"Japan Ministry of Health, Labour and Welfare.
","('Labor_Practices', 0.403964102268219)","('Employee_Health_And_Safety', 0.18643058836460114)","('Human_Rights_And_Community_Relations', 0.09752488881349564)","('NON-ESG', 0.403964102268219)","('NON-ESG', 0.18643058836460114)","('NON-ESG', 0.09752488881349564)"
Line 241,"The 4th NDB Open Data Japan (Cases from Apr 2017 to  Mar 2018).
","('Systemic_Risk_Management', 0.3109455108642578)","('Management_Of_Legal_And_Regulatory_Framework', 0.20966240763664246)","('Data_Security', 0.10546445101499557)","('NON-ESG', 0.3109455108642578)","('NON-ESG', 0.20966240763664246)","('NON-ESG', 0.10546445101499557)"
Line 242,"2019.Design by Addison   www.addison.comStryker | 2019 Annual Review  Hips Power Tools   and Surgical  EquipmentKnees Interventional  SpineAdvanced  Guidance   TechnologiesRobotic-Arm Assisted  Technology Neurosurgical  and ENTMinimally-Invasive   and Open Surgical   Visualization SolutionsTrauma NeurovascularInfrastructure  and IntegrationExtremities Sports Medicine Spinal Implants  and BiologicsEmergency and  Acute CareReprocessing and  RemanufacturingOrthopaedics Neurotechnology and SpineMedical and Surgical equipment Craniomaxillofacial © 2020 Stryker | 2825 Airview Boulevard |  Kalamazoo, MI 49002 USA | stryker.com | SYK Corp 2020-02-Products may not be available in all markets.
","('Employee_Health_And_Safety', 0.3633553087711334)","('Access_And_Affordability', 0.20976153016090393)","('Employee_Engagement_Inclusion_And_Diversity', 0.08926964551210403)","('NON-ESG', 0.3633553087711334)","('NON-ESG', 0.20976153016090393)","('NON-ESG', 0.08926964551210403)"
Line 243,"2019.Design by Addison   www.addison.comStryker | 2019 Annual Review  Hips Power Tools   and Surgical  EquipmentKnees Interventional  SpineAdvanced  Guidance   TechnologiesRobotic-Arm Assisted  Technology Neurosurgical  and ENTMinimally-Invasive   and Open Surgical   Visualization SolutionsTrauma NeurovascularInfrastructure  and IntegrationExtremities Sports Medicine Spinal Implants  and BiologicsEmergency and  Acute CareReprocessing and  RemanufacturingOrthopaedics Neurotechnology and SpineMedical and Surgical equipment Craniomaxillofacial © 2020 Stryker | 2825 Airview Boulevard |  Kalamazoo, MI 49002 USA | stryker.com | SYK Corp 2020-02-Products may not be available in all markets.
","('Product_Design_And_Lifecycle_Management', 0.8880642652511597)","('Product_Quality_And_Safety', 0.02805147133767605)","('Customer_Welfare', 0.017902227118611336)","(['Product Stewardship'], 0.8880642652511597)","('NON-ESG', 0.02805147133767605)","('NON-ESG', 0.017902227118611336)"
Line 244,"Product availability is subject to the regulatory and/or medical practices in individual markets.
","('Selling_Practices_And_Product_Labeling', 0.7577782273292542)","('Customer_Welfare', 0.06897909939289093)","('Product_Quality_And_Safety', 0.055657077580690384)","(['Marketing Practices'], 0.7577782273292542)","('NON-ESG', 0.06897909939289093)","('NON-ESG', 0.055657077580690384)"
Line 245,"Our Annual Review contains many of the valuable trademarks owned and/or used by Stryker and our subsidiaries and affiliates in the U.S. and internationally  to distinguish products and services of outstanding quality.
","('Product_Design_And_Lifecycle_Management', 0.23340754210948944)","('Product_Quality_And_Safety', 0.1664978563785553)","('Selling_Practices_And_Product_Labeling', 0.10764914005994797)","('NON-ESG', 0.23340754210948944)","('NON-ESG', 0.1664978563785553)","('NON-ESG', 0.10764914005994797)"
Line 246,"All other trademarks featured herein are the property of their respective owners.
","('Customer_Privacy', 0.3507373631000519)","('Competitive_Behavior', 0.1352561116218567)","('Business_Ethics', 0.059164438396692276)","('NON-ESG', 0.3507373631000519)","('NON-ESG', 0.1352561116218567)","('NON-ESG', 0.059164438396692276)"
Line 247,"This document is governed solely by applicable U.S. laws and governmental regulations.Additional   information Independent registered   public accounting firm Ernst & Young LLP  Grand Rapids, Michigan Transfer agent and registrar American Stock Transfer &   Trust Company, LLC  New York, New York Shareholders needing information  regarding their certificates or dividends  should contact: American Stock Transfer &   Trust Company, LLC  Operations Center   6201 15th Avenue   New York, New York 11219   800 937 5449   info@amstock.com Investor contact Katherine A.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8107042908668518)","('Business_Ethics', 0.03199109807610512)","('Competitive_Behavior', 0.02457823045551777)","(['Corporate Governance'], 0.8107042908668518)","('NON-ESG', 0.03199109807610512)","('NON-ESG', 0.02457823045551777)"
Line 248,"This document is governed solely by applicable U.S. laws and governmental regulations.Additional   information Independent registered   public accounting firm Ernst & Young LLP  Grand Rapids, Michigan Transfer agent and registrar American Stock Transfer &   Trust Company, LLC  New York, New York Shareholders needing information  regarding their certificates or dividends  should contact: American Stock Transfer &   Trust Company, LLC  Operations Center   6201 15th Avenue   New York, New York 11219   800 937 5449   info@amstock.com Investor contact Katherine A.
","('Business_Model_Resilience', 0.4418695867061615)","('Systemic_Risk_Management', 0.07441440224647522)","('Management_Of_Legal_And_Regulatory_Framework', 0.0502547025680542)","('NON-ESG', 0.4418695867061615)","('NON-ESG', 0.07441440224647522)","('NON-ESG', 0.0502547025680542)"
Line 249,"Owen  Vice President, Strategy and   Investor Relations Media contact Yin C.
","('Business_Model_Resilience', 0.45953577756881714)","('Employee_Engagement_Inclusion_And_Diversity', 0.08774075657129288)","('Director_Removal', 0.053691137582063675)","('NON-ESG', 0.45953577756881714)","('NON-ESG', 0.08774075657129288)","('NON-ESG', 0.053691137582063675)"
Line 250,"Becker  Vice President, Communications,   Public Affairs and Corporate MarketingBusiness development contact Bryant S.
","('Business_Model_Resilience', 0.266022264957428)","('Management_Of_Legal_And_Regulatory_Framework', 0.14324648678302765)","('Employee_Engagement_Inclusion_And_Diversity', 0.1219567060470581)","('NON-ESG', 0.266022264957428)","('NON-ESG', 0.14324648678302765)","('NON-ESG', 0.1219567060470581)"
Line 251,"Zanko  Vice President, Business Development Annual meeting The virtual Annual Meeting of  Shareholders of Stryker Corporation   will be held on Tuesday, May 5, 2020,  at 2:00 p.m. ET.
","('Director_Removal', 0.5235319137573242)","('Business_Model_Resilience', 0.11301542073488235)","('Management_Of_Legal_And_Regulatory_Framework', 0.059679217636585236)","(['Anti-Crime Policy & Measures'], 0.5235319137573242)","('NON-ESG', 0.11301542073488235)","('NON-ESG', 0.059679217636585236)"
Line 252,"Access the meeting online at:  www.virtualshareholdermeeting.com/ SYKOr by phone, listen only:  U.S. (toll free): 1-877-328-2502   International: 1-412-317-Stock listing The company’s common stock is traded  on the New York Stock Exchange under  the symbol SYK.
","('Systemic_Risk_Management', 0.18757274746894836)","('Competitive_Behavior', 0.17879623174667358)","('Business_Model_Resilience', 0.10416184365749359)","('NON-ESG', 0.18757274746894836)","('NON-ESG', 0.17879623174667358)","('NON-ESG', 0.10416184365749359)"
Line 253,"Form 10-K The company files an Annual Report  on Form 10-K with the Securities and  Exchange Commission.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9220685362815857)","('Director_Removal', 0.010990886949002743)","('Business_Ethics', 0.01033426821231842)","(['Corporate Governance'], 0.9220685362815857)","('NON-ESG', 0.010990886949002743)","('NON-ESG', 0.01033426821231842)"
Line 254,"Shareholders   may view the 2019 report at   www.stryker.com or www.sec.gov.Forward-looking statements This Annual Review contains  information that includes or is based  on forward-looking statements within  the meaning of the federal securities  law that are subject to various risks  and uncertainties that could cause our  actual results to differ materially from  those expressed or implied in such  statements.
","('Systemic_Risk_Management', 0.7147118449211121)","('Management_Of_Legal_And_Regulatory_Framework', 0.08182007819414139)","('Competitive_Behavior', 0.04190967231988907)","(['Risk & Crisis Management'], 0.7147118449211121)","('NON-ESG', 0.08182007819414139)","('NON-ESG', 0.04190967231988907)"
Line 255,"Such factors include, but  are not limited to: the failure to satisfy  any of the closing conditions to the  acquisition of Wright Medical, including  the receipt of any required regulatory  clearances (and the risk that such  clearances may result in the imposition  of conditions that could adversely affect  the expected benefits of the transaction);  delays in consummating the acquisition  of Wright; unexpected liabilities, costs,  charges or expenses in connection with  the acquisition of Wright; the effects of  the proposed Wright transaction (or the  announcement thereof) on the parties’  relationships with employees, customers,  other business partners or governmental  entities; the impact of the coronavirus  (COVID-19); weakening of economic  conditions that could adversely affect  the level of demand for our products;  pricing pressures generally, including  cost-containment measures that could  adversely affect the price of or demand for our products; changes in foreign  exchange markets; legislative and  regulatory actions; unanticipated issues  arising in connection with clinical  studies and otherwise that affect U.S.  Food and Drug Administration approval  of new products, including Wright  products; potential supply disruptions;  changes in reimbursement levels from  third-party payors; a significant increase  in product liability claims; the ultimate  total cost with respect to recall-related  matters; the impact of investigative and  legal proceedings and compliance risks;  resolution of tax audits; the impact of  the federal legislation to reform the  United States healthcare system; costs to  comply with medical device regulations;  changes in financial markets; changes in  the competitive environment; our ability  to integrate and realize the anticipated  benefits of acquisitions in full or at  all or within the expected timeframes,  including the acquisition of Wright;  and our ability to realize anticipated  cost savings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9327375888824463)","('Competitive_Behavior', 0.010054638609290123)","('Business_Ethics', 0.00959036499261856)","(['Corporate Governance'], 0.9327375888824463)","('NON-ESG', 0.010054638609290123)","('NON-ESG', 0.00959036499261856)"
Line 256,"Such factors include, but  are not limited to: the failure to satisfy  any of the closing conditions to the  acquisition of Wright Medical, including  the receipt of any required regulatory  clearances (and the risk that such  clearances may result in the imposition  of conditions that could adversely affect  the expected benefits of the transaction);  delays in consummating the acquisition  of Wright; unexpected liabilities, costs,  charges or expenses in connection with  the acquisition of Wright; the effects of  the proposed Wright transaction (or the  announcement thereof) on the parties’  relationships with employees, customers,  other business partners or governmental  entities; the impact of the coronavirus  (COVID-19); weakening of economic  conditions that could adversely affect  the level of demand for our products;  pricing pressures generally, including  cost-containment measures that could  adversely affect the price of or demand for our products; changes in foreign  exchange markets; legislative and  regulatory actions; unanticipated issues  arising in connection with clinical  studies and otherwise that affect U.S.  Food and Drug Administration approval  of new products, including Wright  products; potential supply disruptions;  changes in reimbursement levels from  third-party payors; a significant increase  in product liability claims; the ultimate  total cost with respect to recall-related  matters; the impact of investigative and  legal proceedings and compliance risks;  resolution of tax audits; the impact of  the federal legislation to reform the  United States healthcare system; costs to  comply with medical device regulations;  changes in financial markets; changes in  the competitive environment; our ability  to integrate and realize the anticipated  benefits of acquisitions in full or at  all or within the expected timeframes,  including the acquisition of Wright;  and our ability to realize anticipated  cost savings.
","('Product_Design_And_Lifecycle_Management', 0.8461525440216064)","('Selling_Practices_And_Product_Labeling', 0.028750451281666756)","('Customer_Welfare', 0.02244274877011776)","(['Product Stewardship'], 0.8461525440216064)","('NON-ESG', 0.028750451281666756)","('NON-ESG', 0.02244274877011776)"
Line 257,"Such factors include, but  are not limited to: the failure to satisfy  any of the closing conditions to the  acquisition of Wright Medical, including  the receipt of any required regulatory  clearances (and the risk that such  clearances may result in the imposition  of conditions that could adversely affect  the expected benefits of the transaction);  delays in consummating the acquisition  of Wright; unexpected liabilities, costs,  charges or expenses in connection with  the acquisition of Wright; the effects of  the proposed Wright transaction (or the  announcement thereof) on the parties’  relationships with employees, customers,  other business partners or governmental  entities; the impact of the coronavirus  (COVID-19); weakening of economic  conditions that could adversely affect  the level of demand for our products;  pricing pressures generally, including  cost-containment measures that could  adversely affect the price of or demand for our products; changes in foreign  exchange markets; legislative and  regulatory actions; unanticipated issues  arising in connection with clinical  studies and otherwise that affect U.S.  Food and Drug Administration approval  of new products, including Wright  products; potential supply disruptions;  changes in reimbursement levels from  third-party payors; a significant increase  in product liability claims; the ultimate  total cost with respect to recall-related  matters; the impact of investigative and  legal proceedings and compliance risks;  resolution of tax audits; the impact of  the federal legislation to reform the  United States healthcare system; costs to  comply with medical device regulations;  changes in financial markets; changes in  the competitive environment; our ability  to integrate and realize the anticipated  benefits of acquisitions in full or at  all or within the expected timeframes,  including the acquisition of Wright;  and our ability to realize anticipated  cost savings.
","('Product_Quality_And_Safety', 0.27429601550102234)","('Management_Of_Legal_And_Regulatory_Framework', 0.20542265474796295)","('Selling_Practices_And_Product_Labeling', 0.1565723568201065)","('NON-ESG', 0.27429601550102234)","('NON-ESG', 0.20542265474796295)","('NON-ESG', 0.1565723568201065)"
Line 258,"Such factors include, but  are not limited to: the failure to satisfy  any of the closing conditions to the  acquisition of Wright Medical, including  the receipt of any required regulatory  clearances (and the risk that such  clearances may result in the imposition  of conditions that could adversely affect  the expected benefits of the transaction);  delays in consummating the acquisition  of Wright; unexpected liabilities, costs,  charges or expenses in connection with  the acquisition of Wright; the effects of  the proposed Wright transaction (or the  announcement thereof) on the parties’  relationships with employees, customers,  other business partners or governmental  entities; the impact of the coronavirus  (COVID-19); weakening of economic  conditions that could adversely affect  the level of demand for our products;  pricing pressures generally, including  cost-containment measures that could  adversely affect the price of or demand for our products; changes in foreign  exchange markets; legislative and  regulatory actions; unanticipated issues  arising in connection with clinical  studies and otherwise that affect U.S.  Food and Drug Administration approval  of new products, including Wright  products; potential supply disruptions;  changes in reimbursement levels from  third-party payors; a significant increase  in product liability claims; the ultimate  total cost with respect to recall-related  matters; the impact of investigative and  legal proceedings and compliance risks;  resolution of tax audits; the impact of  the federal legislation to reform the  United States healthcare system; costs to  comply with medical device regulations;  changes in financial markets; changes in  the competitive environment; our ability  to integrate and realize the anticipated  benefits of acquisitions in full or at  all or within the expected timeframes,  including the acquisition of Wright;  and our ability to realize anticipated  cost savings.
","('Competitive_Behavior', 0.6323566436767578)","('Management_Of_Legal_And_Regulatory_Framework', 0.20653276145458221)","('Systemic_Risk_Management', 0.032552171498537064)","(['Business Ethics'], 0.6323566436767578)","('NON-ESG', 0.20653276145458221)","('NON-ESG', 0.032552171498537064)"
Line 259,"Additional information  concerning these and other factors is  contained in our filings with the U.S.  Securities and Exchange Commission,  including our Annual Report on  Form 10-K and Quarterly Reports  on Form 10-Q.","('Management_Of_Legal_And_Regulatory_Framework', 0.9111049771308899)","('Business_Ethics', 0.012913063168525696)","('Director_Removal', 0.00934500340372324)","(['Corporate Governance'], 0.9111049771308899)","('NON-ESG', 0.012913063168525696)","('NON-ESG', 0.00934500340372324)"
